Flexible expandable electrode and method of intraluminal delivery of pulsed power
A surgical instrument, such as an electrical ablation device, includes an elongate member having therealong disposed a first electrode extending along an axis. A first expandable portion extends along the axis and defines a first perimeter of the first electrode and has an associated first diameter with respect to the axis. The first expandable portion includes a first framework selectively expandable to transition the first expandable portion from a contracted state to an expanded state. The first framework is selectively contractible to transition the first expandable portion from the expanded state to the contracted state. When the first framework is expanded, the first diameter is expanded and the first expandable portion is transitioned from the contracted state to the expanded state. When the first framework is contracted, the first diameter is contracted and the first expandable portion is transitioned from the expanded state to the contracted state.
Latest Ethicon Endo-Surgery, Inc. Patents:
Electrical ablation therapy has been used in medicine for the treatment of undesirable tissue, such as, for example, diseased tissue, cancer, malignant and benign tumors, masses, lesions, and other abnormal tissue growths. Apparatuses, systems, and methods for conventional ablation therapies may include electrical ablation therapies, such as, for example, high temperature thermal therapies including, focused ultrasound ablation, radiofrequency (RF) ablation, and interstitial laser coagulation, chemical therapies in which chemical agents are injected into the undesirable tissue to cause ablation, surgical excision, cryotherapy, radiation, photodynamic therapy, Moh's micrographic surgery, topical treatments with 5-fluorouracil, and laser ablation.
Drawbacks of conventional electrical ablation therapies include risk of permanent damage to healthy tissue surrounding undesirable tissue due to exposure to thermal energy and/or lack of controlled energy generated by an electrical ablation device. As such, when undesirable tissue occurs or originates at or near critical structures and surgical resection presents an increased risk of morbidity associated with damage to that critical structure, conventional electrical ablation therapies may be an unsatisfactory alternative. At times, the ability to apply controlled energy to ablate cells within a target zone may be affected by one or more characteristics of the target zone and/or available application positions provided by ablative electrodes. Solutions to address the above issues are often invasive and conflict with optimal surgical outcomes. Accordingly, minimally invasive electrical ablation therapy capable of accurately targeting ablative electrodes to a target site and delivering controlled energy to ablate cells within a target zone while retaining necessary infrastructure of the surrounding tissue is desirable.
SUMMARYIn one general aspect, the various embodiments are directed to an electrical ablation device. One embodiment of the electrical ablation device includes an elongate member having therealong disposed a first electrode extending along an axis. The first electrode has a proximal end configured to couple to an energy source and a surface configured to couple to a tissue treatment region and delivery ablative energy. A first expandable portion extends along the axis and defines a first perimeter of the first electrode and has an associated first diameter with respect to the axis. The first expandable portion includes a first framework comprising at least one first framework member. The first framework is selectively expandable to transition the first expandable portion from a contracted state to an expanded state. The first framework is selectively contractible to transition the first expandable portion from the expanded state to the contracted state. When the first framework is expanded, the first diameter is expanded and the first expandable portion is transitioned from the contracted state to the expanded state. When the first framework is contracted, the first diameter is contracted and the first expandable portion is transitioned from the expanded state to the contracted state.
In another general aspect, a method of treating tissue using the electrical ablation devices described herein includes delivering the first electrode to a tissue treatment region that includes a biological lumen and expanding the first electrode. The first electrode is contacted to a wall of the lumen proximal to tissue to be treated. Tissue is treated by applying one or more sequences of electrical pulse to the first electrode to induce cell death in the tissue by irreversible electroporation.
The various embodiments of electrical ablation devices, systems, and methods thereof described herein may be better understood by considering the following description in conjunction with the accompanying drawings.
The present disclosure relates generally to the field of electrosurgery. In particular, the present disclosure relates to, although not exclusively, electrosurgical devices. More particularly, the present disclosure relates to, although not exclusively, electrical ablation systems, devices, and methods.
This disclosure describes various elements, features, aspects, and advantages of various embodiments of electrical ablation systems, devices, and methods thereof. It is to be understood that certain descriptions of the various embodiments have been simplified to illustrate only those elements, features and aspects that are relevant to a more clear understanding of the disclosed embodiments, while eliminating, for purposes of brevity or clarity, other elements, features and aspects. Any references to “various embodiments,” “certain embodiments,” “some embodiments,” “one embodiment,” or “an embodiment” generally means that a particular element, feature and/or aspect described in the embodiment is included in at least one embodiment. The phrases “in various embodiments,” “in certain embodiments,” “in some embodiments,” “in one embodiment,” or “in an embodiment” may not refer to the same embodiment. Furthermore, the phrases “in one such embodiment” or “in certain such embodiments,” while generally referring to and elaborating upon a preceding embodiment, is not intended to suggest that the elements, features, and aspects of the embodiment introduced by the phrase are limited to the preceding embodiment; rather, the phrase is provided to assist the reader in understanding the various elements, features, and aspects disclosed herein and it is to be understood that those having ordinary skill in the art will recognize that such elements, features, and aspects presented in the introduced embodiment may be applied in combination with other various combinations and sub-combinations of the elements, features, and aspects presented in the disclosed embodiments. It is to be appreciated that persons having ordinary skill in the art, upon considering the descriptions herein, will recognize that various combinations or sub-combinations of the various embodiments and other elements, features, and aspects may be desirable in particular implementations or applications. However, because such other elements, features, and aspects may be readily ascertained by persons having ordinary skill in the art upon considering the description herein, and are not necessary for a complete understanding of the disclosed embodiments, a description of such elements, features, and aspects may not be provided. As such, it is to be understood that the description set forth herein is merely exemplary and illustrative of the disclosed embodiments and is not intended to limit the scope of the invention as defined solely by the claims.
All numerical quantities stated herein are approximate unless stated otherwise, meaning that the term “about” may be inferred when not expressly stated. The numerical quantities disclosed herein are to be understood as not being strictly limited to the exact numerical values recited. Instead, unless stated otherwise, each numerical value is intended to mean both the recited value and a functionally equivalent range surrounding that value. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding the approximations of numerical quantities stated herein, the numerical quantities described in specific examples of actual measured values are reported as precisely as possible.
All numerical ranges stated herein include all sub-ranges subsumed therein. For example, a range of “1 to 10” is intended to include all sub-ranges between and including the recited minimum value of 1 and the recited maximum value of 10. Any maximum numerical limitation recited herein is intended to include all lower numerical limitations. Any minimum numerical limitation recited herein is intended to include all higher numerical limitations. Additionally, in some illustrative embodiments, a parameter, measurement, diversion, or range may be given. It is to be understood that any such parameter, measurement, diversion, or range is provided as an illustrative example or instance of an embodiment and is not intended to limit that or other embodiments.
As generally used herein, the terms “proximal” and “distal” generally refer to a clinician manipulating one end of an instrument used to treat a patient. The term “proximal” generally refers to the portion of the instrument closest to the clinician. The term “distal” generally refers to the portion located furthest from the clinician. It will be further appreciated that for conciseness and clarity, spatial terms such as “vertical,” “horizontal,” “up,” and “down” may be used herein with respect to the illustrated embodiments. However, surgical instruments may be used in many orientations and positions, and these terms are not intended to be limiting and absolute.
As generally used herein, the term “ablation” generally refers to removal of cells either directly or indirectly by supply of energy within an electric field and may include removal by loss of cell function, cell lysis, necrosis, apoptosis, and/or irreversible electroporation. “Ablation” may similarly refer to creation of a lesion by ablation. Additionally, the terms “undesirable tissue,” “target cells,” “diseased tissue,” “diseased cells,” “tumor,” “cell mass” and the like are generally used throughout to refer to cells removed or to be removed, in whole or in part, by ablation and are not intended to limit application of the systems, devices, or methods described herein. For example, such terms include ablation of both diseased cells and certain surrounding cells, despite no definite indication that such surrounding cells are diseased. The terms similarly include ablation of cells located around a biological lumen such as a vascular, ductal, or tract area, for example, to create a margin for a surgeon to resect additional cells by ablation or other method.
According to certain embodiments, an ablation system generally comprises first and second electrodes coupled to an energy source operative to generate an electric field between the first and second electrodes when such electrodes are contacted to tissue and energized. An electrical current supplied to the electric field is conducted between the first and second electrode through the tissue. Without wishing to be bound to any particular theory, it is believed the electrical current propagates through conductive tissue at least partially via electron and/or electrolytic carriers. Electrical ablation devices may generally comprise one or more electrodes configured to be positioned at or near undesirable tissue (e.g., target cells, target site, treatment site, diseased tissue, diseased cells, tumor, cell mass) in a tissue treatment region (e.g., a target region). In general, the electrodes may comprise an electrically conductive portion (e.g., medical grade stainless steel, gold plated, etc.) and may be configured to electrically couple to an energy source. Once positioned at or near undesirable tissue, an energizing potential may be applied to the electrodes to create an electric field to which the undesirable tissue is exposed. The energizing potential (and the resulting electric field) may be characterized by various parameters, such as, for example, frequency, amplitude, pulse width (duration of a pulse or pulse length), and/or polarity. Depending on the desired application, for example, the diagnostic or therapeutic treatment to be rendered, a particular electrode may be configured either as an anode or a cathode, or a plurality of electrodes may be configured with at least one electrode configured as an anode and at least one other electrode configured as a cathode. Regardless of the initial polarity configuration, the polarity of the electrodes may be reversed by reversing the polarity of the output of the energy source. In some embodiments, an exogenous electrolyte may be applied to tissue prior to ablation to increase conductivity. In certain embodiments, application of an exogenous electrolyte may increase or decrease an effective area or density of an electric field.
In certain embodiments, a suitable energy source may comprise an electrical waveform generator. The energy source generates an electric field having a suitable characteristic waveform output in terms of frequency, amplitude, pulse width, and polarity. Electrodes may be energized with DC voltages and conduct currents at various frequencies, amplitudes, pulse widths, and polarities. The electrodes may also be energized with time-varying voltages and currents at amplitudes and frequencies suitable for rendering the desired therapy. A suitable energy source may comprise an electrical waveform generator adapted to deliver DC and/or time-varying energizing potentials characterized by frequency, amplitude, pulse width, and/or polarity to the electrodes. The electric current flows between the electrodes and through the tissue proportionally to the potential (e.g., voltage) applied to the electrodes. In various embodiments, supplied electric current is provided by the energy source and comprises a pulse sequence applied to tissue. For example, an energy source may supply various waveforms in one or more pulse sequences tailored to the desired application. Commonly owned U.S. patent application Ser. No. 13/036,908, filed Feb. 28, 2011, titled “ELECTRICAL ABLATION DEVICES AND METHODS,” and U.S. patent application Ser. No. 13/352,495, filed Jan. 18, 2012, titled “ELECTRICAL ABLATION DEVICES AND METHODS,” disclose many such waveforms, pulse sequences, and methods of application thereof for electrical ablation treatment, the contents of which are herein incorporated by reference.
In one embodiment, the energy source may be configured to produce RF waveforms at predetermined frequencies, amplitudes, pulse widths, and/or polarities suitable for thermal heating and/or electrical ablation of cells in the tissue treatment region. One example of a suitable RF energy source may be a commercially available conventional, bipolar/monopolar electrosurgical RF generator, such as Model Number ICC 350, available from Erbe, GmbH. In one embodiment, the energy source may comprise a microwave energy source configured to produce microwave waveforms at predetermined frequencies, amplitudes, pulse widths, and/or polarities suitable for thermal heating and/or electrical ablation of cells in the tissue treatment region. The microwave power source, such as MicroThermx, available from Boston Scientific Corp., may be coupled to a microwave antenna providing microwave energy in the frequency range from 915 MHz to 2.45 GHz.
In one embodiment, the energy source may be configured to produce destabilizing electrical potentials (e.g., fields) suitable to induce thermal heating and/or irreversible electroporation. The destabilizing electrical potentials may be in the form of bipolar/monopolar monophasic electric pulses suitable for inducing thermal heating and/or irreversible electroporation. A commercially available energy source suitable for generating thermal heating and/or irreversible electroporation electric field pulses in bipolar or monopolar mode is a pulsed DC generator such as Model Number ECM 830, available from BTX Molecular Delivery Systems Boston, Mass. In bipolar mode, the first electrode may be electrically coupled to a first polarity and the second electrode may be electrically coupled to a second (e.g., opposite) polarity of the energy source. Bipolar/monopolar monophasic electric pulses may be generated at a variety of frequencies, amplitudes, pulse widths, and/or polarities. Unlike RF ablation systems, which may require high power and energy levels delivered into the tissue to heat and thermally destroy the tissue, irreversible electroporation may require very little energy applied to the tissue to heat and kill the cells of the undesirable tissue using electric field potentials rather than heat. Accordingly, irreversible electroporation systems may avoid the detrimental thermal effects caused by RF ablation systems.
Various embodiments of the electrical ablation systems, devices, and methods described herein utilize electroporation or electropermeabilization techniques to apply external electric fields (electric potentials) to cell membranes to significantly increase permeability of the plasma membrane of the cell. Irreversible electroporation (IRE) is the process of killing cells by increasing the electrical potential across the cell membrane for a long period of time. IRE provides an effective method for destroying cells while avoiding some of the negative complications of heat-inducing therapies. Namely, IRE kills cells without raising the temperature of the surrounding tissue to a level at which permanent damage may occur to the support structure or regional vasculature. Large destabilizing IRE electric potentials may be in the range of about several hundred to about several thousand volts applied in the tissue to increase the local electric field. The increase in the electric field will increase the membrane potential over a distance of about several millimeters, for example, for a relatively long period of time. The destabilizing electric potential forms pores in the cell membrane when the potential across the cell membrane reaches a critical level causing the cell to die by processes known as apoptosis and/or necrosis.
Application of IRE pulses to cells may be an effective way for ablating large volumes of undesirable tissue with no or minimal detrimental thermal effects to the surrounding healthy tissue. As such, in some embodiments, IRE may be utilized in conjunction with the various electrodes and/or other electrical ablation devices disclosed herein to perform one or more minimally invasive surgical procedures or treatments. Without wishing to be bound to any particular theory, it is believed that IRE destroys cells with no or minimal heat, and thus, may not destroy the cellular support structure or regional vasculature. A destabilizing irreversible electroporation pulse, suitable to cause cell death without inducing a significant amount of thermal damage to the surrounding healthy tissue, may have amplitude in the range of several hundred to several thousand volts and may be generally applied across biological membranes over a distance of several millimeters, for example, for a relatively long duration of 1 μs to 100 ms. Thus, the undesirable tissue may be ablated in-vivo through the delivery of destabilizing electric fields by quickly causing cell necrosis.
In certain embodiments, the energy source may comprise a wireless transmitter to deliver energy to the electrodes using wireless energy transfer techniques via one or more remotely positioned antennas. Those skilled in the art will appreciate that wireless energy transfer or wireless power transmission refers to the process of transmitting electrical energy from an energy source to an electrical load without interconnecting wires. In one embodiment, the energy source may be coupled to first and second electrodes by a wired or a wireless connection. In a wired connection, the energy source may be coupled to the electrodes by way of the electrical conductors. In a wireless connection, the electrical conductors may be replaced with a first antenna coupled the energy source and a second antenna coupled to the electrodes, wherein the second antenna may be remotely located from the first antenna. In one embodiment, the energy source may comprise a wireless transmitter to deliver energy to the electrodes using wireless energy transfer techniques via one or more remotely positioned antennas. As previously discussed, wireless energy transfer or wireless power transmission is the process of transmitting electrical energy from the energy source to an electrical load, e.g., the abnormal cells in the tissue treatment region, without using the interconnecting electrical conductors. An electrical transformer is the simplest example of wireless energy transfer. The primary and secondary circuits of a transformer may not be directly connected and the transfer of energy may take place by electromagnetic coupling through a process known as mutual induction. Power also may be transferred wirelessly using RF energy.
As will be appreciated, the electrical ablation devices, systems, and methods may comprise portions that may be inserted into the tissue treatment region percutaneously (e.g., where access to inner organs or other tissue is done via needle-puncture of the skin). Other portions of the electrical ablation devices may be introduced into the tissue treatment region endoscopically (e.g., laparoscopically and/or thoracoscopically) through trocars or channels of the endoscope, through small incisions, or transcutaneously (e.g., where electric pulses are delivered to the tissue treatment region through the skin).
The systems, devices, and methods for electrical ablation therapy may be adapted for use in minimally invasive surgical procedures to access tissue treatment regions in various anatomic locations, such as, for example, the brain, lungs, breast, liver, gall bladder, pancreas, prostate gland, and various internal body or biological lumen (e.g., a natural body orifice) defined by the esophagus, stomach, intestine, colon, arteries, veins, anus, vagina, cervix, fallopian tubes, and the peritoneal cavity. Minimally invasive electrical ablation devices may be introduced to the tissue treatment region though a small opening formed in the patient's body using a trocar or through a natural body orifice such as the mouth, anus, or vagina using translumenal access techniques known as Natural Orifice Translumenal Endoscopic Surgery (NOTES)™ wherein electrical ablation devices may be initially introduced through a natural body orifice and then advanced to the tissue treatment site by puncturing the walls of internal body lumen. In various embodiments, the electrical ablation system may be adapted to treat undesirable tissue in the brain, lung, breast, liver, gall bladder, pancreas, or prostate gland, using one or more electrodes positioned percutaneously, transcutaneously, translumenally, minimally invasively, and/or through open surgical techniques, or any combination thereof.
In certain embodiments, the systems, devices, and methods may be configured for minimally invasive ablation treatment of cell masses, tumors, growths, or other undesirable tissue. Minimally invasive ablation treatment of undesirable tissue may be characterized by the ability to reduce trauma by accurately targeting undesirable tissue through one or more biological lumens (e.g., a natural body orifice, vascular, duct, or tract area) and applying an electric field to ablate undesirable tissue in a controlled and focused manner while at the same time retaining the cellular infrastructure of the surrounding healthy tissue. According to various embodiments, delivering an electrode to a biological lumen and contacting the lumen wall in a controlled manner provides increased electroablative accuracy which may reduce undesirable lesions, increase probability of desirable circumferential ablation zones, and/or retain necessary infrastructure in surrounding tissue. For example, uniformity and/or density of an electric field over particular regions of the electric field established by various electrodes and/or returns may be more precisely focused or controlled. In certain embodiments, contacting a lumen wall in a controlled manner comprises circumferentially contacting the lumen wall at two or more locations about the circumference of the wall at or near a treatment site, for example, at or along two locations about the circumference of the wall separated by 15°, 30°, 90°, or 180°, for example. Such contact may be continuous, such as contact connecting two points, or discontinuous, such as contact at a first point and at a second point without contact along at least an intervening portion of the lumen wall between the first and second points.
When a tissue treatment region is located at or near a biological lumen, such as a vascular, duct, cavity, orifice, or tract area, for example, minimally invasive electrical ablation devices comprising electrodes may be delivered to the tissue treatment region through an artificial lumen (e.g., channel of endoscope, sheath, sleeve, trocar) and/or through one or more biological lumens, as herein described. In various embodiments, an electrical ablation device (e.g., electrode or an electrode disposed along a probe comprising an elongate member) may be fed through the biological lumen within an endoscope, trocar, sheeth, sleeve, or channel, for example. An electrical ablation device may also be configured to be fed through a biological lumen “naked,” that is, without assistance from the above instruments. For example, an electrode may be configured to be flexibly fed or directed through one or more biological lumens to the treatment region. In some embodiments, electrodes may be provided along a distal portion of an elongate member comprising a probe. The elongate member may thereby be configured to deliver one or more electrodes to a tissue region. Portions of the elongate member proximal to an electrode may respond to signals from a clinician directing one or more of such positions along a length of the elongate member to move. For example, an elongate member may be responsive to signals to bend at the one or more positions along its length during delivery to a tissue region. Once electrical ablation devices (e.g., electrodes) are delivered or located at or near undesirable tissue in the treatment region, electrodes may be deployed to contact lumen tissue and apply ablative treatment. Such bending, therefore, may assist in navigation and/or placement of the electrical ablation device through or within a biological lumen during delivery, deployment, or during or after ablative treatment.
In particular embodiments, electrodes may be configured to expand circumferentially, for example, when deployed or once located at or near undesirable tissue within a tissue region. Expansion may be the result of deployment, an electrical, mechanical, chemical, or thermal signal actuating an expansion, or, in some instances, a contraction. In some embodiments, electrodes may be configured to expand in at least one dimension. For example, electrodes may be configured to expand in diameter. Electrodes may further be configured to expand in length, such as extending a length of the electrode. In some embodiments, an extension in length may be independent of an expansion in diameter. For example, electrodes may expand in length without expanding in diameter or may expand in diameter without expanding in length. In other embodiments, however, an expansion in diameter or length may be concomitant with an increase or decrease in diameter or length. In certain embodiments, electrodes may be configured to expand only in diameter or length. In various embodiments, electrodes expandable in one or more dimensions may be similarly configured to contract in one or more dimensions. Such electrodes may be said to be transitionable between an expanded state and a contracted state. In some embodiments, transitions between one or more expanded states and one or more contracted states may be in response to a signal provided by a clinician. Thus, in some embodiments, a clinician may selectively transition an electrode to a desired expanded and/or contracted state to beneficially fit an electrode to a desired application, such as a procedure and/or biological structure. In certain instances, selecting an expanded state may provide increase contact about a circumference of a lumen thereby creating a more precisely defined electric field and increasing controllability of electric field potentials, for example. In various embodiments, an electrode may comprise an antenna, such as a microwave antenna, wherein undesirable tissue positioned adjacent to or near the antenna may be more fully exposed to ablative energy when the electrode is in an expanded state compared to a contracted state. For example, a diameter, length, and/or surface area of an electrode comprising antenna may be increased in the expanded state such undesirable tissue is fully exposed to ablative energy.
An electrical ablation system 10 incorporating an electrical ablation device 12 according to one embodiment is illustrated in
In
The electrical ablation system 10 illustrated in
In some embodiments, electrodes 21, 22 may deliver electric field pulses to the undesirable tissue. Such electric field pulses may be characterized by various parameters, such as, for example, pulse shape, amplitude, frequency, pulse width, polarity, total number of pulses and duration. In various embodiments, the electric field pulses may be sufficient to induce thermal heating in the undesirable tissue without inducing irreversible electroporation in the undesirable tissue. In certain embodiments, the electric field pulses may be sufficient to induce irreversible electroporation in the undesirable tissue. The effects induced may depend on a variety of conditions, such as, for example, tissue type, cell size, and electrical field pulse parameters. For example, the transmembrane potential of a specific tissue type may primarily depend on the amplitude of the electric field and pulse width.
In one embodiment, the input to the energy source 11 may be connected to a commercial power supply by way of a plug (not shown). The output of the energy source 11 is coupled to electrodes 21, 22, which may be energized using an activation switch (not shown) on the handle 14, or an activation switch mounted on a foot activated pedal (not shown). The energy source 11 may be configured to generate electric pulses at a predetermined frequency, amplitude, pulse width, and/or polarity that are suitable to induce thermal heating in the undesirable tissue in the treatment region or induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region. The polarity of the DC pulses may be reversed or inverted from positive-to-negative or negative-to-positive a predetermined number of times to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region.
In some embodiments, one or more series of electric pulses may be applied to induce IRE. In one embodiment, a timing circuit may be coupled to the output of the energy source 11 to generate electric pulses. The timing circuit may comprise one or more suitable switching elements to produce the electric pulses. For example, the energy source 11 may produce a series of m electric pulses (where m is any positive integer) of sufficient amplitude and duration less than the necrotic threshold to induce thermal heating in the undesirable tissue when the m electric pulses are applied and a series of n electric pulses (where n is any positive integer) of sufficient amplitude and duration to induce irreversible electroporation suitable for tissue ablation when the n electric pulses are applied. In various embodiments, the electric pulses may have a fixed or variable pulse width, amplitude, and/or frequency.
The electrical ablation device 12 may be operated either in bipolar mode, e.g., the electrodes are relatively close to one another, or monopolar mode, e.g., the electrodes are far apart and one electrode typically has a much larger surface area. For example, the electrodes 21, 22 may be employed in a bipolar electrical ablation system in which the first electrode 21 has a positive polarity relative to the other electrode 22. In monopolar mode, a grounding pad, as illustrated in
Returning to
In various embodiments, the elongate member 18 may be flexible along all or a portion of its length. Such flexible portions may be bendable, deformable, or elastic, for example. Flexible portions may also be conditionally flexible or conditionally rigid, for example. In some embodiments, the elongate member 18 comprises flexible portions which may be mechanically bendable such that portions of the elongate member 18 are pivotable in response to a signal or otherwise manipulatable. In some embodiments, the elongate member 18 may be proximally and/or distally advanced relative to the handle 14. A distal advance of the elongate member 18 relative to the distal end of the handle 14, for instance, may coincide with a distal advance of the elongate member 18 relative to the proximal end of the handle 14. In certain embodiments, when advancing the elongate member 18 increases a length of the elongate member 18, distal to the distal end of the handle 14, the increase in length coincides with a decrease in length of the elongate member 18 proximal to the proximal end of the handle 14. In various embodiments, a proximal advance of the elongate member 18 relative to the distal end of the handle 14 coincides with a proximal advance of the elongate member 18 relative to the proximal end of the handle 14. In certain embodiments, when advancing the elongate member 18 decreases a length of the elongate member 18 distal to the distal end of the handle 14, the decrease in length coincides with an increase in length of the elongate member 18 proximal to the proximal end of the handle 14. While the elongate member 18 illustrated in
In some embodiments, one or more portions of the elongate member 18 may be coiled, nested, or otherwise contained within the handle 14 or a distal portion of the elongate member 18. In some such embodiments, a distal advance of the elongate member 18 relative to the distal end of the handle 14 does not coincide with a distal advance of the elongate member 18 relative to the proximal end of the handle 14. In one such embodiment, a proximal advance of the elongate member 18 relative to the distal end of the handle 14 does not coincide with a proximal advance of the elongate member 18 relative to the proximal end of the handle 14. In certain embodiments, when advancing the elongate member 18 increases a length of the elongate member 18 distal to the distal end of the handle 14, the length of the elongate member 18 proximal to the proximal end of the handle 14 remains the same. In one such embodiment, when advancing the elongate member 18 decreases a length of the elongate member 18 distal to the distal end of the handle 14, the length of the elongate member 18 proximal to the proximal end of the handle 14 remains the same.
In certain embodiments, the electrical ablation system 10 comprises a relatively flexible elongate member 18 and may be introduced, directed, and delivered to a tissue treatment region within the sheath 40. The sheath 40 may be a hollow bore, such as a tube, for example. In some embodiments, the sheath 40 is semi-rigid and may be used to accurately deliver the first electrode 21 to a tissue treatment region. The elongate member 18 may be translatable through the hollow bore to alternately withdraw and deploy one or more electrode(s) 21, 22 or a portions thereof. In some embodiments, the elongate member 18 comprises an extendable portion, such as an extendable length. The length may be extendable by, for example, distally extending the elongate member 18 such that the elongate member 18 distally elongates relative to the distal end of the handle 14, thus advancing or deploying the first electrode 21 or a portion thereof. Similarly, an actuator, such as slide assembly 34, may be provided to extend the elongate member 18. For example, the elongate member 18 may advance or deploy the first electrode 21 or a portion thereof by distally feeding an additional length of the elongate member 18. It is to be appreciated that extension of the elongate member 18 is not limited to feeding additional elongate member 18 distally from the handle 14. In some embodiments, a portion of the elongate member 18 may extend by moving a first portion of the elongate member 18 relative to a second portion of the elongate member 18. The first and second portions of the elongate member 18 may flank both sides of a nested portion such that a relative movement between the first and second portions of the elongate member 18 may thereby result from a telescopic extension or retraction of a length of the elongate member 18, increasing or decreasing the overall length of the elongate member 18. The first and second portions of the elongate member 18 may also flank both sides of a folded portion of the elongate member 18 such that a relative movement between the first and second portions of the elongate member 18 may thereby result from a folding or unfolding of the folded portion resulting in an accordion-like extension or retraction of a length of the elongate member 18. Relative movement between first and second portions may be accomplished by any known mechanism, such as pulleys, reciprocating extension members, slide mounts, gears, and/or tracks, for example. In some embodiments, the elongate member 18 may advance or deploy the first electrode 21 by progressive release of a bias within the elongate member 18. In the embodiment illustrated in
As previously described, the elongated member 18 may comprise a distally located tip 28. In certain embodiments, the tip 28 may include an insulator configured to resist conduction of electric current. It is to be appreciated that tips 28 of various dimensions may be provided to suit particular applications. For example, in some embodiments, the length of the tip 28 may be longer than the first electrode 21 while in other embodiments the length of the tip 28 may be shorter than the first electrode 21. Tips 28 of various lengths may beneficially increase stability of the first electrode 21 during ablation or assist delivery of the first electrode 21 by, for example, increasing steerability of the elongate member 18. In various embodiments, a diameter of the tip 28 may be greater than or less than a diameter of the first electrode 21 in a contracted state. In some such embodiments, the tip 28 may comprise multiple diameters. Tips 28 comprising multiple diameters may be configured to assist in delivery, placement, and/or positioning of the first electrode 21. For example, contours provided about the multiple diameters of the tip 28 may be designed to anchor or fitably position the first electrode 21 at or near a treatment site. Such contours may also include one or more surface features configured to grippably engage tissue at or near a treatment site. In various embodiments, the tip 28 comprises a distal end configured to assist in delivery, placement and/or positioning of the first electrode 21. For example, a distal end of the tip 28 may comprise a dull or blunt end, as illustrated in
In various embodiments, the slide assembly 34 is operatively coupled to the sheath 40 such that movement of the slide member 30 in a first direction advances the sheath 40 relative to the distal end of the handle 14 and movement of the slide member 30 in a second direction retracts the sheath relative to the distal end of the handle 14. In some embodiments, the sheath may be retractable relative to the distal end of the handle 14 to expose or deliver the first electrode 21 to a deployed position at or near a treatment site. In some embodiments, the sheath 40 may be advanceable relative to the distal end of the handle 14 to envelope or withdraw the first electrode 21 to a withdrawn position. It will be appreciated that the elongate member 18 may be advanceable by arrangements other than the slide member 30, such as a lever, trigger, actuator, or button, for example, and advancement or retraction may be effectuated manually, electrically, and/or mechanically, for example. In one embodiment, the elongate member 18 may be advanced or retracted by increasing or decreasing a length of the elongate member 18. For example, one or more electrodes 21 or other portions of the elongate member 18 may comprise an adjustable length comprised of an elastic or otherwise extendable or compressible material such that an adjustment of the length effectuates an advancement or retraction of the elongate member 18. In some embodiments, a distal advancement of the elongate member 18 deploys the first electrode 21 to target tissue and a proximal retraction of the elongate member 18 withdraws the first electrode 21 from target tissue. In some embodiments, one or more actuators may be configured to deploy the first electrode 21 to a treatment region, to withdraw the first electrode 21 from a treatment region, to extend or flex the first electrode 21, and/or to transition the expandable portion 20 between contracted and expanded states. In some embodiments, multiple transitions may be actuated by the same or different actuators. For example, an actuation signal to transition between a contracted state and an expanded state may be coupled with an actuation signal to withdraw or deploy the first electrode 21.
In various embodiments, first and second electrodes 21, 22 may be disposed along the distal portion of the elongate member 18 and may be employed to more precisely define a treatment area to, for example, ablate undesirable tissue while reducing muscle contractions in adjoining tissues.
In some embodiments, where the elongate member comprises multiple electrodes, the distance “d” between electrodes may be adjustable. Referring again to
According to the various embodiments of electrical ablation systems, devices, and methods disclosed herein, electrodes 21 may comprise flexible and/or expandable portions. In some instances, such flexible and/or expandable portions may include a framework comprising one or more framework members providing, which may provide structure to the flexible and/or expandable portions. In various embodiments, a framework defines a selectively expandable perimeter and/or diameter of the expandable portion and may include one or more energy delivery surfaces configured to contact tissue and deliver ablative energy. Herein, the generalized shape and periphery surfaces of expandable and/or flexible portions may be generally referred to as a basket. It is to be appreciated that the electrodes in
Framework members may be configured to flex or bend in one or more directions and may comprise flexible materials exhibiting elastic and/or reflexive properties. For example, framework members may comprise materials such as plastics, polymers, alloys, metallics, or other elastics including superelastics. Framework members may similarly comprise rigid or conditionally rigid materials configures to flex or bend about a joint or socket, for example. In some embodiments, a clinician may decrease trauma associated with directing electrodes through tortuous biological lumens by utilizing a flexible electrode 21. Flexible electrodes 21 may beneficially reach undesirable tissues in target regions that may otherwise be considered inoperable. In various embodiments, flexible electrodes 21 may also increase the contact area between tissue contact regions of the flexible electrodes 21 and undesirable tissue. As those having skill in the art will recognize, flexible electrodes 21 may be especially helpful by providing greater control over an application when, for example, undesirable tissue is partially obstructing a biological lumen.
In various embodiments, electrodes 21 may be expandable in any physical dimension, such as, for example, width or height. In some embodiments, for instance, an expansion of an electrode 21 may be described as an increase in a diameter of the electrode 21. As generally used herein, the term “diameter” generally means a straight line distance between two points located along a perimeter of an expandable portion 20 such that the straight line passes through the axis of the expandable portion 20. The perimeter of an expandable portion 20 may comprise a periphery or external surface of the expandable portion 20. For example, in some embodiments, the framework 50 defines a perimeter of the expandable portion 20 and a diameter may be the distance between two tissue contact regions on opposing sides of the framework. It is to be appreciated that diameter is not limited to a specific geometric shape or cross-section and includes helical, circular, triangular, rectangular, pentagonal, hexagonal, or any other suitable shape, be it a regular geometric shape or irregular, for example.
In addition to expandability and/or flexibility, an electrode 21 may also be extendable. That is, a length of the electrode 21 may be extendable by extending a movable portion of the electrode 21 relative to a fixed portion of the electrode 21. For example, in one embodiment of the flexible electrode 21 illustrated in
In various embodiments, an electrical ablation device 12 comprises one or more expandable electrodes 21. Expandable electrodes 21, such as those illustrated in
The degree to which a dimension of an expandable portion 20 may expand may be many multiples of the original value of the dimension. For example, a dimension of an expandable portion 20 in a first state may have a value of 1 and the dimension of the expandable portion 20 in a second state may have a value of 2, 3, 10, 20 or greater, such as 40. In certain embodiments, the degree of expansion is limited only by the length of the expandable portion 20 in the first state. In some embodiments, a variable expansion feature is provided. A variable expansion feature may enable the clinician to adjust the degree to which an electrode 21 expands. For example, a clinician may adjust the degree of expansion to a predetermined diameter before or during a procedure. A variable expansion feature may also be configured to adapt to a procedure or provide feedback to the clinician such that the degree of expansion may be adjusted. For example, the magnitude of an expansion force may be finite and/or nominal after a particular degree of expansion has taken place such that degree of expansion may be limited when external resistance to expansion is at or near a predetermined threshold, for example, when a wall or structure is obstructing a full expansion. Such a variable expansion feature may be further adjustable to tailor to specific applications. For example, an electrode 21 comprising a conductive balloon may be inserted into a lumen and inflated by controllable pressure to substantially conform to the shape of the lumen. Such a complementary shape may increase circumferential contact about the lumen without exerting an invasive force on tissue. Similarly, in various embodiments, framework members 52 retain at least partial flexibility when the expandable portion 20 is in the expanded state. For example, framework members 52 may be flexible inward toward the axis and/or outward of the axis. The elongate member 18 and/or expandable portion 20 may similarly be flexible away from the axis at various angles and directions. In some embodiments, an adaptable feature includes an electrode 21 wherein the length of the expandable portion 20 may be adjustable. For example, in some embodiments, an expandable portion 20 may be withdrawn or received within the sheath 40 such that only the portion of the expandable portion 20 that remains deployed is expanded when the expandable portion 20 is selectively transitioned to the expanded state.
According to various embodiments, electrodes 21 or expandable portions 20 thereof may be selectively transitioned between a contracted state and one or more expanded states.
In some embodiments, transitioning an expandable portion 20 from a contracted state to an expanded state may be driven by an expansion force. Expansion forces may be applied to one or more framework members 52 to effectuate an expansion. Expansion forces may comprise any known force, such as torque, compression, or tension, for example. In one embodiment, for instance, changes in internal pressure drive transitions using an injectable, such as a solid, liquid, or gas, injected into or released from a cavity defined within a framework 50. Increase in interior pressure may expand the framework 50 to an equilibrium pressure in one or more regions of the framework 50 or may drive further expansion by increasing tension about the cavity of the framework 50. Similarly, contraction forces may be applied to one or more framework members 52 to drive a contraction, such as a contraction between an expanded state and a less expanded state. Contraction forces may comprise any known force, such as torque, compression, and tension, for example, to decrease a dimension. For example, in one embodiment, changes in internal pressure drive transitions using an injectable, such as a solid, liquid, or gas, injected into or released from a cavity defined within a framework 50. Decrease in interior pressure, such as a release of an injectable, may contract the framework 50 to an equilibrium pressure in one or more regions of the framework 50 by relieving tension about the cavity or may drive further contraction by releasing additional injectable, thereby allowing external pressure to compress the framework 50 and occupy the cavity.
In various embodiments, electrical ablation devices 12 may employ compression, tension, and/or rotation to transition electrodes 21 or expandable portions 20 between contracted and expanded states. In some embodiments, compression of framework members 52 may decrease a length of the expandable portion 20 while, at the same time, increase a diameter of the expandable portion 20. For example, compressed framework members 52 may strain, bow, or bend outward of the axis to relieve compressive stress. Compression may also drive a repositioning of framework members 52 within the framework 50 to effectuate a transition that increases a diameter of an expandable portion 20 without decreasing a length of the expandable portion 20. For example, one or more framework members 52 or portions thereof may be urged outward of the axis or along the elongate member 18 resulting in repositioning of those or other framework members 52 and an increase in a dimension of the expandable portion 20. In some embodiments, tension of framework members 52 may increase a length of the expandable portion 20 while, at the same time, decreasing a diameter of the expandable portion 20. For example, otherwise bowed or outward extending framework members 52 may be tensioned to strain, stretch, or straighten inward toward the axis as to relieve tension stress. Tension may also drive repositioning of framework members 52 within the framework 50 to effectuate a transition that increases a diameter of the expandable portion 20 without decreasing a length of the expandable portion 20. For example, one or more framework members 52 or portions thereof may be pulled inward toward the axis or along the elongate member 18 resulting in repositioning of those or other framework members 52 and a decrease in a dimension of the expandable portion 20. In some embodiments, a rotation of a first coupler configured to couple manipulations effectuating relative movements between framework members 52 or portions thereof relative to a second coupler may increases or decreases a distance between framework members 52 or portions thereof. For example, a decrease in the distance may compress one or more intervening portions or other framework members 52 while an increase in the distance may tension one or more intervening portions or framework members 52.
In various embodiments, framework members 52 comprise memory materials. Memory materials may include reflexive and/or elastic materials configured to return to a memory orientation or arrangement following removal of a deformative stress. For example, in some embodiments, framework members 52 are configured to be deformed by a deformative stress above or below an elastic limit and return to a memory form upon removal of the deformative stress and/or subsequent manipulation, such as a change in temperature. In certain embodiments, memory materials include shape memory materials having one-way and/or two-way memory effect. Memory materials may also include materials that may be deformable and reformable by manipulation. For example, a first counter rotation between two portions of a coil may partially unwind the coil while a second counter rotation, opposite of the first, may rewind the coil. Materials having such properties are known in the art and include polymers such as memory foams, plastics, elastomers, and rubbers as well as metallics and alloys. It is to be appreciated that such materials include superelastics and shape memory materials, such as alloys (e.g., NiTi), ceramics, and polymers including gels, foams, and solids. Notably, when framework members 52 comprise memory materials that are poor conductors, conductive materials may be used to establish an electrical path for ablative energy to be transmitted and delivered to tissues. For example, conductive coatings, wires, sleeves, and/or tissue contact regions may be used to transmit and deliver energy to tissue. In some embodiments, elastic limits of framework members 52 may be increased due to arrangement and/or orientation of framework members 52. For example, framework members 52 may comprise configurations of coils or braids comprising increased elastic limits due to, for example, distributed strains.
In various embodiments, framework members 52 a memory form that may be manipulated or otherwise deformed or retained by a retaining force and upon removal of the retaining force, the material at least partially returns to the memory form. Framework members 52 having a memory form may be arranged within the expandable portion 20 in any suitable manner such that the framework members 52 will return to the memory form following removal of a retaining force or upon manipulation. For example, a framework 50 comprising a conductive coating and including framework members 52 comprising a foam polymer may be configured to expand in at least one dimension upon removal of a retaining force and contract in the at least one dimension upon application of the retaining force. In certain embodiments, the retaining force is provided by a channel (e.g., an artificial channel defined within an endoscope, trocar, or sheath) in which the expandable portion 20 is received. Other retaining structures may also be used to apply a retaining force. For example, hooks, latches, constrictable loops, or other retaining mechanisms may be employed in certain embodiments to retain framework members 52 and/or prevent framework members 52 from transitioning to one or more memory forms.
Framework members 52 may individually or collectively have one or more memory forms and/or retained forms. For example, framework members 52 may deform in response to a retaining force and return to a memory form when the retaining force is removed. Alternately, framework members 52 may comprise a first memory form and a second memory form wherein when one or more framework members 52 are in the first memory form the expandable portion 20 is in an expanded state and wherein when one or more of the framework members 52 are in the second memory form, the expandable portion 20 is in a contracted state. In certain embodiments, the memory form may correspond to the expanded state and thus comprises an increased diameter compared to the retained form or may correspond to the contacted state and thus comprises a decreased diameter compared to the retained form. Of course, in some embodiments, a retaining force may be combined with and or coupled to a second, third, or plurality of additionally forces to effectuate an active transition between contracted and expanded states.
Framework members 52 may be configured to deform or strain to reduce a diameter of the expandable portion 20 when framework members 52 are compressed toward the axis or are otherwise retained. In this way, an electrode 21 may be directed to a tissue treatment region within an artificial channel in a contracted state and be expandable upon deployment at or near the tissue treatment site and/or in response to removal of the retaining force. In one embodiment, a first framework member 52 comprising a bias, such as a spring, foam, or other memory material, is biased outward of the axis, such as radially. When the expandable portion 20 is pushed, pulled, or rotated within a channel having a diameter less than a diameter of the expandable portion 20 in the expanded state, the channel compresses the first framework member 52 toward the axis, retaining it in a retained form. However, when the expandable portion 20 is pushed, pulled, or rotated from the channel, the first framework member 52 is no longer retained by the channel and, therefore, transitions to the memory form upon deployment and extends outward of the axis. In a further embodiment, a second framework member 52 extends proximally toward the channel when the expandable portion 20 is deployed and in the expanded state. The second framework member 52 comprises a proximal lip and a distal compression surface coupled to the outward extending portion of the first framework member 52. When the expandable portion 20 is received within the channel, the proximal lip is progressively drawn into the channel, leveraging the distal compression surface toward the axis, compressing the first framework member 52, and decreasing a diameter of the expandable portion 20.
Still referring to
The expandable portion 20 in the expandable state illustrated in
The framework members 52 illustrated in
In some embodiments, framework members 52 are arranged as a regular or an irregular grouping of looped coils, braids, or folds occupying a portion of the expandable portion. In various embodiments, framework members 52 may comprise a material, orientation, and/or arrangement imparting the framework members 52 with a memory form when loads are within an associated elastic limit. For example, a framework member 52 may comprise a spring (e.g., a bow, compression, torsion, or tension spring) having an associated memory form and associated elastic limit. The spring may increase or decrease in a dimension in response to an application or removal of a load. When springs are coils or helixes wound about the axis, framework members 52 may be at least partially unwound when the expandable portion 20 is in the contracted state and framework members 52 may be rewound when the expandable portion 20 is in the expanded state. Framework members 52 comprising coils or helixes may also comprise a changed diameter upon application or removal of a load when, for example, a load longitudinally strains a spring. In this way, a clinician may, for example, increase a diameter of a framework member 52 by compressing a compression spring or releasing tension applied to a tension spring. Similarly, a clinician may, for example, decrease a diameter of a framework member 52 by releasing a compressive load applied to a compression spring or apply a tension to a tension spring. Thus, framework members 52 may undergo deformative strains, such as linear or torsion, in a retained form and transition to a memory form upon removal or reversal of a load or force.
In various embodiments, framework members 52 may be braided to form one or more baskets along a length of the expandable portion 20. In one embodiment, framework members 52 are braided into a general cylindrical or tube-like arrangement as illustrated in
In additional embodiments, framework members 52 may be arranged in one or more concentric coils (e.g., loops or wrappings) of framework members 52 arranged about the axis. An outer band of the coil may thereby be rotatable relative to an inner band of the coil such that the expandable portion 20 may be transited between contracted and expanded states by relative rotations between the bands. Such framework members 52 may further comprises an associated memory form and an associated retained form such that a relative rotation between bands comprises a retain force and transitions the expandable portion 20 from the expanded state to the contracted state and a release of the retaining force transitions the expandable portion 20 from the contracted state to the expanded state. In other embodiments, however, a relative rotation between bands may transition the expandable portion 20 from the contracted state to the expanded state and a release of a retaining force may transition the expandable portion 20 from the expanded state to the contracted state. It is to be appreciated that multiple coils comprising multiple bands rotatable relative to one another such that various diameters along the length of the expandable portion 20 may be used to adjustable diameters of the expandable portion 20 to meet various applications.
In various embodiments, electrical ablation devices 12 comprise movable portions. Movable portions may comprise framework couplers and/or movable elements including rings, blocks, or collars disposed about or along the elongate member 18. Movable portions may be slidable along a tract, rotatable about threads, or movable along a distance of the elongate member 18, for example. Elongate members 18 and/or expandable portions 20 may further comprise an adjustable distance such that a movable portion does not physically transition along an elongate member 18 but rather moves as a result of a decrease or increase in the relative distance between the movable portion and another movable portion or position along the elongate member 18 or with respect to the axis. For example, an elongate member 18 may comprise an adjustable distance wherein an adjustment in the distance results in a first movable portion moving relative to a second movable portion. In certain embodiments, the distance between movable portions may be adjusted by extending or retracting a folded or nested portion of the adjustable distance, for example. Extending or retracting may be accomplished by, for example, relative rotations, release of a bias, and/or application of counter or relative forces between two portions. In one embodiment, an electric ablation device 12 comprises a movable portion such as a block, ring, coupler, or other element comprising an abutment surface. The element may be configured to be movable along an elongate member 18 and abut a framework member 52. In some embodiments, movement of the element applies a compressive stress to framework members 52 or relieves a compressive strain. In various embodiments, pulleys or gears may also be employed to move movable portions. For example, movable portions may ride along a track defined along the elongate member 18. The track may include gears configured to move a movable portion or adjust a length of the elongate member 18 between movable portions, for example, by nesting a portion of the elongate member 18.
In various embodiments, framework members 52 may be movable with respect to the elongate member 18. One or more framework members 52 or portions thereof may be configured to slide along or pivot with respect to the elongate member 18. For example, a first portion of a framework member 52 may be fixed or pivotably fixed to the elongate member 18 at a first position and a second portion of the framework member 52 may be fixed or pivotably fixed to the elongate member 18 at a second position.
It is to be appreciated that the proximal and distal orientation is provided to assist in the understanding of the systems, devices, and methods disclosed herein. In certain embodiments orientations and/or arrangements may be reversed such that the goal of transitioning an expandable portion remains that same. For example, the distal coupler 56 may be rotatably movable upon threads, for instance, provided near the distal coupler 56. Such orientational variations do not deviate from this disclosure. Indeed, in one embodiment, the proximal coupler 54 and the distal coupler 56 are rotatable about threads provided about the surface of the elongate member 18. Similarly, in another embodiment, the distal coupler 56 is clickably movable along the elongate member 18. In further embodiments, a series of framework 50 arrangements and/or expandable portions 20 may be disposed along the distal portion of the elongate member 18. Such a series of framework 50 arrangements and/or expandable portions 20 may be configured for a desired application and provide customizable ablation zones within a biological lumen or treatment site.
In certain embodiments, framework members 52 may comprise a coil operatively coupled to the elongate member 18 at a first position. In such an embodiment, relative counter rotation between the first position and a second position at least partially unwinds the coil and corresponds to an increase in a diameter of the expandable portion 20. For example, when the framework member 52 is a right-handed coil or helix a clockwise rotation of a proximal position relative to a distal position transitions the expandable portion 20 between the contracted state and an expanded state while a counterclockwise rotation of the proximal position relative to the distal position transitions the expandable portion 20 from an expanded state to the contracted state. Similarly, when the framework member 52 is a left-handed coil or helix a clockwise rotation of the distal position relative to the proximal position transitions the expandable portion 20 from the contracted state to an expanded state while a counterclockwise rotation of the distal position relative to the proximal position transitions the expandable portion 20 from an expanded state to a more contracted state. In a similar embodiment, the longitudinal distance between the proximal and distal positions is also adjustable. For example, the proximal position may be slidable toward the distal position, thus, reducing the distance between the two. In one embodiment, one or both positions are threadably rotatable about the elongate member 18 such that rotation of the positions increases or decreases the distance between the proximal and distal positions. In other embodiments, one or both positions are clickably or slidably positionable along the elongate member 18. It is to be appreciated that a coil may be rotatable at multiple positions such that various diameters along the length of the expandable portion 20 may be adjustable to meet various applications.
As previously described, one or a multiple of methods may be employed to effectuate a relative movement between a first movable portion comprising a proximal portion of framework members 50, such as a proximal coupler, and a second movable portion comprising a distal portion of framework members 52, such as a distal coupler. For example, in some embodiments, a clinician may engage an interface to signal actuation or a relative movement between the first and second portions. Actuation signals may trigger transitions effectuated by mechanical and/or electrical elements. In certain embodiments, an actuator comprises a manipulator configured to manually extend or retract portions of framework members 52 and/or portions of the elongate member 18. A signal may result in a rotation of a coupler about a threaded track, as in
In the embodiment illustrated in
In some embodiments, a sheath 40 is not provided and an electrode 21 may be delivered to a target region within another delivery device. In some such embodiments, the electrode 21 may be delivered to the target region naked, that is, not within an artificial channel. In these and other embodiments, the electrode 21 may be delivered to a target region by advancing the elongate member 18 through a biological orifice or lumen. Once delivered to the target region, the electrode 21 may be expanded in response to an actuation signal. The electrical ablation device 12 illustrated in
In various embodiments, the elongate member 18 may be flexible along all or a portion of its length. Such flexible portions may be bendable, deformable, or elastic, for example. Flexible portions may also be conditionally flexible or conditionally rigid. In some embodiments, the elongate member 18 comprises flexible portions which may be mechanically bendable such that portions of the elongate member 18 are pivotable in response to a signal or otherwise manipulable. In one embodiment, the elongate member 18 comprises a maneuverable portion configured to maneuver within a biological lumen such as vascular, duct, cavity, orifice, or tract area, for example, and deliver an electrode 21, to a target site. In one embodiment, a cardiac catheter platform comprises one or more electrodes 21 disposed along the distal portion of a flexible and/or maneuverable elongate member 18 configured to deliver the one or more electrodes 21 into chamber, vessel, or a surface of the heart to endocardially ablate spots for treatment for atrial fibrillation, for example. The one or more electrodes 21 may be selectively expandable between contracted and expanded states. In some embodiments, multiple electrodes 21 are disposed along the distal portion of the elongate member 18 and spaced to deliver energy to cardiac tissue within a tightly controlled electric field. In some such embodiments, the distance between electrodes 21 along the distal portion of the elongate member 18 may be adjustable to conform to a particular procedure.
Referring to
In various embodiments, electrical ablation devices 12 include accessory features such as optics, applicators, and sensors. For example, transducers or sensors may be located in the handle 14, or tip 28, or other suitable location to sense, for example, the force required to expand an electrode 21. This feedback information may be useful to determine whether electrodes 21 have been properly positioned within a biological lumen at or near a tissue treatment site. Manual actuation of an expandable portion 20 may similarly provide feedback to a clinician regarding the force required to fully expand the expandable portion 20. In this way, the clinician may decide that full expansion of the expandable portion 20 is either unnecessary or may otherwise result in unnecessary trauma and adjust the degree of expansion accordingly. In certain embodiments, feedback is provided to the clinician to physically sense when an electrode 21 is placed at or near a tissue treatment site. In some embodiments, feedback information provided by the transducers or sensors may be processed and displayed by circuits located either internally or externally to the energy source 11. Sensor readings may be employed, for example, to determine whether an electrode 21 has been properly located at or near a tissue treatment site thereby assuring a suitable margin of error has been achieved in locating the electrode 21. Sensor readings may also be employed, for example, to determine whether pulse parameters need to be adjusted to achieve a desired result, such as, for example, reducing the intensity of muscular contractions in the patient.
In one embodiment, an electrical ablation device 12 includes an accessory feature comprising an electrolyte applicator. An electrolyte applicator may be configured to apply or deliver an exogenous electrolyte at or near a tissue treatment site. An electrolyte applicator may include a delivery portion and a reservoir portion. In some instances, the delivery portion may comprise the reservoir portion. The reservoir portion may be configured to contain electrolyte for delivery. The delivery portion may be configured to deliver electrolyte at or near the tissue treatment site. In some embodiments, the delivery portion comprises a channel adjacent to or within the elongate member 18 or sheath 40. In one embodiment, the delivery portion comprises the tip 28. A clinician may actuate an actuator located on the handle 14, for example, to deliver electrolyte from the delivery portion. In certain embodiments, the delivery portion may be deployable independent of the electrode 21 from a lumen or artificial channel. In some embodiments, the delivery portion, reservoir portion, or the electrolyte applicator may be separate from the electrical ablation system 10. In various embodiments, the delivery portion of an electrolyte applicator may apply an aqueous electrolyte solution to the treatment area prior to or during a treatment to increase conductivity. In other embodiments, however, no solution may be added or a separate or same accessory feature may be configured to apply suction to a treatment area to, for example, remove fluids prior to or during a treatment.
In certain embodiments, at least one of a temperature sensor and pressure sensor may be located in or proximate the electrical ablation system 10. The temperature sensor and/or pressure sensor may be located within the handle 14, protective sleeve 38, sheath 40, elongate member 18, at the distal end of the elongate member 18, such as the tip 28, or within one or more electrodes 21. In certain embodiments, the temperature sensor and/or pressure sensor may be separate from the electrical ablation system 10. The temperature sensor and pressure sensor may provide feedback to the operator, surgeon, or clinician to apply an electric field pulse to the undesirable tissue. The pressure and/or temperature information may be useful to determine whether the undesirable tissue may be treated having reduced or no detrimental thermal effects to surrounding healthy tissue. According to certain embodiments, the temperature sensor may measure the temperature of the tissue treatment region, undesirable tissue, or the area surrounding one or more electrodes before, during, and/or after treatment such as before and/or after the first and/or second sequences of electrical pulses are delivered to the tissue. According to certain embodiments, the pressure sensor may measure the pressure of the tissue treatment region, the space between the electrodes, and/or the area surrounding one or more electrodes before, during, and/or after treatment, such as before and/or after the first and/or second sequences of electrical pulses are delivered to the tissue.
The electrical ablation system 10 may be employed to ablate undesirable tissue in delicate zones or near critical structures and be deployed through a biological lumen, such as vascular, ducts, or tract areas. The electrical ablation system 10 may be configured to treat a number of lesions and osteopathologies comprising metastatic lesions, tumors, fractures, infected sites, and inflamed sites in a tissue treatment region using electrical energy. The electrical ablation devices 12 may be configured to be positioned within a patient's natural body orifice, e.g., the mouth, anus, and vagina, and/or advanced through internal body lumen or cavities, e.g., the esophagus, stomach, intestines, colon, cervix, and urethra, to reach the tissue treatment region. For example, an elongate member 18 may be configured to be positioned and passed through a small incision or keyhole formed through the patient's skin or abdominal wall using a trocar to reach the tissue treatment region. The tissue treatment region may be located in the patient's brain, lung, breast, liver, gall bladder, pancreas, prostate gland, various internal body lumen defined by the esophagus, stomach, intestine, colon, arteries, veins, anus, vagina, cervix, fallopian tubes, and the peritoneal cavity. The electrical ablation system 10 may be used in conjunction with endoscopic, laparoscopic, thoracoscopic, open surgical procedures via small incisions or keyholes, percutaneous techniques, transcutaneous techniques, and/or external non-invasive techniques, and any combinations thereof.
In one embodiment, the electrical ablation device 12 may be employed in conjunction with an artificial channel (e.g., a flexible endoscope, as well as a rigid endoscope, laparoscope, or thoracoscope, such as the GIF-100 model available from Olympus Corporation). In one embodiment, the endoscope may be introduced to the tissue treatment region trans-anally through the colon, trans-orally through the esophagus and stomach, trans-vaginally through the cervix, transcutaneously, or via an external incision or keyhole formed in the abdomen in conjunction with a trocar. The electrode 21 may thereby be delivered to a tissue treatment region via insertion and guided into or proximate the tissue treatment region using the endoscope. Such delivery may also be accomplished using other various artificial channels. The endoscope or other artificial channel may define one or more channels for receiving additional devices such as a light source and a viewing port. Images within the field of view of the viewing port may be received by an optical device, such as, for example, a camera comprising a charge coupled device (CCD) usually located within the endoscope, and transmitted to a display monitor (not shown) outside the patient. In other embodiments, the endoscope is not utilized, and the electrical ablation device 12 comprises a light source and/or a viewing port, for example. Still additional embodiments employ other techniques to determine proper instrument placement, such as, for example, ultrasound or a computerized tomography (CT) scan.
According to one embodiment, methods of electrically ablating tissue include delivering a first electrode 21 to a tissue treatment region. The first electrode 21 may be configured to couple to the energy source and to a tissue treatment region located within or near a lumen. In one embodiment the first electrode 21 is delivered or directed into a lumen at or near a tissue treatment region through a hollow bore, such as an artificial channel. The first electrode 21 may then be deployed at or near a tissue treatment site. Once deployed, an expandable portion 20 of the first electrode 21 may be expanded in at least one dimension (e.g., diameter or length) and then contacted with the lumen wall. A second electrode 22 may be coupled to the first electrode 21 and the patient such that the second electrode 22 is in conductive communication with the first electrode 21 through the patient and represents a difference in electric potential with respect to the first electrode 21. For example, in some embodiments, the second electrode 22 may be a ground or return pad, a needle electrode, or medical clamp in contact or conductive communication with the patient. In various embodiments, the second electrode 22 may be a separately placed electrode, such as a conductive material, return pad, needle, or clamp, for example, may be located at a near by or adjacent tissue, surface, or lumen. Once delivered to a tissue treatment region, the first electrode 21 may be actuated (e.g., deployed, expanded, and energized) to ablate the undesirable tissue.
In some embodiments, expanding an expandable portion 20 of a first electrode 21 comprises transitioning the expandable portion 20 from a contracted state to an expanded state. Transitioning an electrode 21 from a contracted state to an expanded state may comprise increasing at least one dimension of the electrode 21. In certain embodiments, when the expandable portion 20 transitions from the contracted state to the expanded state, a diameter of the expandable portion 20 proportionally decreases in length. In other embodiments, however, the diameter of the expandable portion 20 does not expand proportionally to a decrease in length.
In some embodiments, the first electrode 21 may be alternately or selectively transitionable between a contracted state and an expanded state. In certain embodiments, a transition from a contracted state to an expanded state comprises a relative movement between two portions of a framework or framework members 52. The relative movement may be rotational or longitudinal. For example, a decrease in the distance between two portions of a framework 50 or framework members 52 may transition an expandable portion 20 from a contracted state to an expanded state. Relative movement may result in one or more framework members 52 extending outward of the axis. Outward extension may be the result of bowing of one or more framework members 52. Framework members 52 extending outward of the axis may similarly prop-up, extend, or otherwise reposition other framework members 52 outward of the axis. Various memory materials and orientations of framework members 52 may be employed to assist in transitioning an expandable portion 20 between contracted and expanded states. For example, framework members 52 may be arranged as springs, coils, braids, multi-member baskets, umbrellas, and injectable cavities and may comprise rigid, jointed, or memory materials, including shape set memory superelastics. For example, framework members 52 may comprise metallics, alloys, rubbers, plastics, polymers, and various conductive materials.
In various embodiments, expanding an electrode comprises expanding a diameter or radius or of the expandable portion many times that of the electrode in a contracted state. Depending on the desired application, electrodes may expand 2, 5, 10, 20, 40 or more times in diameter or radius to expand to a diameter conforming to a diameter of a tissue treatment region comprising a biological lumen, such as, for example, a larynx. In various embodiments, the diameter of the first electrode may by different from the diameter of the second electrode. Similarly, in some embodiments, the first electrode may have a different length than the second electrode. Again, depending on the desired application, such variations are contemplated and are considered within this disclosure. As is to be appreciated, when multiple electrodes are disposed along the distal portion of an elongate member, various spacing between the electrodes may also be desirable. In some such embodiments, the distance from the first electrode to the second electrode may be adjusted from 0.5 cm to 3 cm, such as, for example, 1 cm, 1.5 cm, 2.0 cm, and 3 cm. However, in other applications it may be desirable to greatly increase the distance between first and second electrodes to, for example, customize the size of the electric field to a particular application.
Electrodes 21 may be introduced, delivered, deployed, or expanded according to any of the above methods and then contacted with a lumen wall. Contact with a lumen wall is preferably at least partially circumferential. Electrical current may then be applied in various pulse power outputs, such as monophasic square waves, biphasic square waves, RF modulated high voltage, or nanosecond duration pulses, for example. The applied current and waveform can be customized for the desired application and clinical goal to provide various tissue effects such as cell lysis, apoptosis, or irreversible electroporation.
Although the various embodiments of the devices have been described herein in connection with certain disclosed embodiments, many modifications and variations to those embodiments may be implemented. For example, different types of end effectors such as tips, electrodes, and elongate members may be employed. Also, where materials are disclosed for certain components, other materials may be used. The foregoing description and following claims are intended to cover all such modification and variations.
Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
Claims
1. An electrical ablation device, comprising:
- an elongate member;
- a first electrode disposed along the elongate member and extending along an axis, the first electrode having a proximal end configured to couple to an energy source and a surface configured to couple to a tissue treatment region and apply ablative energy; and
- a first expandable portion having a proximal end and a distal end and extending along the axis, the first expandable portion defining a first perimeter of the first electrode and having an associated first diameter with respect to the axis, wherein the first expandable portion comprises a first framework comprising a framework member, wherein the framework member comprises a helix extending along the first expandable portion, wherein a distal end of the framework member is configured to deliver electric current,
- wherein the first framework is selectively expandable to transition the first expandable portion from a contracted state to an expanded state, and the first framework is selectively contractible to transition the first expandable portion from the expanded state to the contracted state,
- wherein, when the first framework is expanded, the first diameter is expanded and the first expandable portion is transitioned from the contracted state to the expanded state,
- wherein, when the first framework is contracted, the first diameter is contracted and the first expandable portion is transitioned from the expanded state to the contracted state,
- wherein a relative rotation between a proximal portion and a distal portion of the framework member transitions the first expandable portion between the contracted state and the expanded state, and
- wherein the relative rotation between the proximal portion and the distal portion of the framework member comprises a counter rotation of the distal portion of the framework member relative to the proximal portion of the framework member.
2. The electrical ablation device of claim 1, wherein the first electrode comprises a first flexible portion, and wherein at least a portion of the first expandable portion comprises at least a portion of the first flexible portion.
3. The electrical ablation device of claim 1, wherein the first framework is expandable to expand the first diameter to circumferentially contact a biological lumen at two or more locations about the circumference of a biological lumen.
4. The electrical ablation device of claim 1, wherein the framework member has an associated memory form and an associated retained form, and wherein the framework member is transitionable between the memory form and the retained form to expand and contract the first framework.
5. The electrical ablation device of claim 4, further comprising a retaining structure configured to retain the framework member in the retained form.
6. The electrical ablation device of claim 5, wherein the retaining structure comprises a sheath defining a channel configured to receive the framework member within a distal portion thereof, wherein the framework member is deployable from a distal end of the distal portion of the sheath, wherein the framework member is transitioned from the retained form to the memory form when deployed from the distal end of the sheath.
7. The electrical ablation device of claim 1, wherein the framework member is transitionable between an associated low temperature form and an associated high temperature form.
8. The electrical ablation device of claim 1, wherein the first framework further comprises a proximal and a distal coupler configured to couple the framework member within the first framework, wherein the proximal and distal couplers are separated by a distance, and wherein a transition from the contracted state to the expanded state further comprises a decrease in the distance between the proximal coupler and the distal coupler.
9. The electrical ablation device of claim 8, wherein the decrease in the distance between the proximal and distal coupler pivots at least a portion of the framework member outward of the axis.
10. The electrical ablation device of claim 1, further comprising:
- a second electrode disposed along the elongate member and extending along the axis, the second electrode having a proximal end configured to couple to the energy source and a surface configured to couple to the tissue treatment region;
- a second expandable portion having a proximal end and a distal end and extending along the axis, the second expandable portion defining a second perimeter of the second electrode having an associated second diameter with respect to the axis, wherein the second expandable portion comprises a second framework comprising one or more second framework members; and
- the second framework selectively expandable to transition the second expandable portion from a contracted state to an expanded state, and the second framework selectively contractible to transition the second expandable portion from the expanded state to the contracted state, wherein, when the second framework is expanded, the second diameter is expanded and the second expandable portion is transitioned from the contracted state to the expanded state, and wherein, when the second framework is contracted, the second diameter is contracted and the second expandable portion is transitioned from the expanded state to the contracted state.
11. The electrical ablation device of claim 10, wherein the first electrode and the second electrode are separated by a distance along the elongate member, and wherein the distance between the first electrode and the second electrode is selectively adjustable.
12. A method of electrosurgically treating tissue, comprising:
- obtaining the electrical ablation device of claim 1;
- delivering the first electrode to a tissue treatment region comprising a biological lumen;
- expanding the first electrode;
- contacting the first electrode to a wall of the biological lumen proximal to the tissue to be treated; and
- treating the tissue by applying, with the first electrode, one or more sequences of electric pulses to the tissue to be treated sufficient to induce cell death in the tissue by irreversible electroporation.
13. The method of electrosurgically treating tissue of claim 12, further comprising rotating the helix in a first direction within the biological lumen to continuously treat the entire biological lumen.
14. An electrical ablation device, comprising:
- an elongate member;
- a first electrode disposed along the elongate member and extending along an axis, the first electrode having a proximal end configured to wirelessly couple to an energy source and a surface configured to couple to a tissue treatment region and apply ablative energy; and
- a first expandable portion having a proximal end and a distal end and extending along the axis, the first expandable portion defining a first perimeter of the first electrode and having an associated first diameter with respect to the axis, wherein the first expandable portion comprises a first framework comprising a framework member, wherein the framework member comprises a helix extending along the first expandable portion,
- wherein a distal end of the framework member is configured to deliver electric current,
- wherein the first framework is selectively expandable to transition the first expandable portion from a contracted state to an expanded state, and the first framework is selectively contractible to transition the first expandable portion from the expanded state to the contracted state,
- wherein a relative rotation between a proximal portion and a distal portion of the framework member transitions the first expandable portion between the contracted state and the expanded state, and
- wherein the relative rotation between the proximal portion and the distal portion of the framework member comprises a counter rotation of the distal portion of the framework member relative to the proximal portion of the framework member.
15. An electrical ablation device, comprising:
- an elongate member;
- an electrode disposed along the elongate member and extending along an axis, the electrode having a proximal end configured to couple to an energy source and a surface configured to couple to a tissue treatment region and apply ablative energy; and
- an expandable portion comprising a proximal end and a distal end and extending along the axis, the expandable portion defining a perimeter of the electrode and having an associated diameter with respect to the axis, wherein the expandable portion comprises a framework comprising a framework member, wherein the framework member comprises a helix extending along the expandable portion,
- wherein the framework is selectively expandable to transition the expandable portion from a contracted state to an expanded state, and the framework is selectively contractible to transition the expandable portion from the expanded state to the contracted state,
- wherein a relative rotation between a proximal portion and a distal portion of the framework member transitions the expandable portion between the contracted state and the expanded state, and
- wherein the relative rotation between the proximal portion and the distal portion of the framework member comprises a counter rotation of the distal portion of the framework member relative to the proximal portion of the framework member.
112794 | March 1871 | Felton |
645576 | March 1900 | Tesla |
649621 | May 1900 | Tesla |
787412 | April 1905 | Tesla |
1039354 | September 1912 | Bonadio |
1127948 | February 1915 | Wappler |
1482653 | February 1924 | Lilly |
1581706 | April 1926 | White |
1581707 | April 1926 | White |
1581708 | April 1926 | White |
1581709 | April 1926 | White |
1581710 | April 1926 | White |
1625602 | April 1927 | Gould et al. |
1916722 | July 1933 | Ende |
2028635 | January 1936 | Wappler |
2031682 | February 1936 | Wappler et al. |
2113246 | April 1938 | Wappler |
2137710 | November 1938 | Anderson |
2155365 | April 1939 | Rankin |
2191858 | February 1940 | Moore |
2196620 | April 1940 | Attarian |
2388137 | October 1945 | Graumlich |
2451077 | October 1948 | Emsig |
2493108 | January 1950 | Casey, Jr. |
2504152 | April 1950 | Riker et al. |
2938382 | May 1960 | De Graaf |
2952206 | September 1960 | Becksted |
3044461 | July 1962 | Murdock |
3069195 | December 1962 | Buck |
3070088 | December 1962 | Brahos |
3110956 | November 1963 | Fischer, Jr. |
3170471 | February 1965 | Schnitzer |
3435824 | April 1969 | Gamponia |
3470876 | October 1969 | Barchilon |
3481325 | December 1969 | Glassman |
3595239 | July 1971 | Petersen |
3669487 | June 1972 | Roberts et al. |
3746881 | July 1973 | Fitch et al. |
3799672 | March 1974 | Vurek |
3854473 | December 1974 | Matsuo |
3854743 | December 1974 | Hansen |
3929123 | December 1975 | Jamshidi |
3946740 | March 30, 1976 | Bassett |
3948251 | April 6, 1976 | Hosono |
3961632 | June 8, 1976 | Moossun |
3965890 | June 29, 1976 | Gauthier |
3994301 | November 30, 1976 | Agris |
4011872 | March 15, 1977 | Komiya |
4012812 | March 22, 1977 | Black |
4043342 | August 23, 1977 | Morrison, Jr. |
4071028 | January 31, 1978 | Perkins |
4085743 | April 25, 1978 | Yoon |
4164225 | August 14, 1979 | Johnson et al. |
4170997 | October 16, 1979 | Pinnow et al. |
4174715 | November 20, 1979 | Hasson |
4178920 | December 18, 1979 | Cawood, Jr. et al. |
4207873 | June 17, 1980 | Kruy |
4235238 | November 25, 1980 | Ogiu et al. |
4258716 | March 31, 1981 | Sutherland |
4269174 | May 26, 1981 | Adair |
4278077 | July 14, 1981 | Mizumoto |
4281646 | August 4, 1981 | Kinoshita |
4285344 | August 25, 1981 | Marshall |
4311143 | January 19, 1982 | Komiya |
4329980 | May 18, 1982 | Terada |
4393872 | July 19, 1983 | Reznik et al. |
4396021 | August 2, 1983 | Baumgartner |
4396139 | August 2, 1983 | Hall et al. |
4406656 | September 27, 1983 | Hattler et al. |
4452246 | June 5, 1984 | Bader et al. |
4461281 | July 24, 1984 | Carson |
4491132 | January 1, 1985 | Aikins |
4492232 | January 8, 1985 | Green |
4527331 | July 9, 1985 | Lasner et al. |
4527564 | July 9, 1985 | Eguchi et al. |
4538594 | September 3, 1985 | Boebel et al. |
D281104 | October 22, 1985 | Davison |
4569347 | February 11, 1986 | Frisbie |
4580551 | April 8, 1986 | Siegmund et al. |
4646722 | March 3, 1987 | Silverstein et al. |
4649904 | March 17, 1987 | Krauter et al. |
4653476 | March 31, 1987 | Bonnet |
4655219 | April 7, 1987 | Petruzzi |
4657016 | April 14, 1987 | Garito et al. |
4657018 | April 14, 1987 | Hakky |
4669470 | June 2, 1987 | Brandfield |
4671477 | June 9, 1987 | Cullen |
4677982 | July 7, 1987 | Llinas et al. |
4685447 | August 11, 1987 | Iversen et al. |
4711239 | December 8, 1987 | Sorochenko et al. |
4711240 | December 8, 1987 | Goldwasser et al. |
4712545 | December 15, 1987 | Honkanen |
4721116 | January 26, 1988 | Schintgen et al. |
4727600 | February 23, 1988 | Avakian |
4733662 | March 29, 1988 | DeSatnick et al. |
D295894 | May 24, 1988 | Sharkany et al. |
4742817 | May 10, 1988 | Kawashima et al. |
4753223 | June 28, 1988 | Bremer |
4763669 | August 16, 1988 | Jaeger |
4770188 | September 13, 1988 | Chikama |
4790624 | December 13, 1988 | Van Hoye et al. |
4791707 | December 20, 1988 | Tucker |
4796627 | January 10, 1989 | Tucker |
4807593 | February 28, 1989 | Ito |
4815450 | March 28, 1989 | Patel |
4819620 | April 11, 1989 | Okutsu |
4823794 | April 25, 1989 | Pierce |
4829999 | May 16, 1989 | Auth |
4836188 | June 6, 1989 | Berry |
4846573 | July 11, 1989 | Taylor et al. |
4867140 | September 19, 1989 | Hovis et al. |
4869238 | September 26, 1989 | Opie et al. |
4869459 | September 26, 1989 | Bourne |
4873979 | October 17, 1989 | Hanna |
4880015 | November 14, 1989 | Nierman |
4904048 | February 27, 1990 | Sogawa et al. |
4911148 | March 27, 1990 | Sosnowski et al. |
4926860 | May 22, 1990 | Stice et al. |
4934364 | June 19, 1990 | Green |
4938214 | July 3, 1990 | Specht et al. |
4950273 | August 21, 1990 | Briggs |
4950285 | August 21, 1990 | Wilk |
4953539 | September 4, 1990 | Nakamura et al. |
4960133 | October 2, 1990 | Hewson |
4977887 | December 18, 1990 | Gouda |
4979496 | December 25, 1990 | Komi |
4979950 | December 25, 1990 | Transue et al. |
4984581 | January 15, 1991 | Stice |
4990152 | February 5, 1991 | Yoon |
4991565 | February 12, 1991 | Takahashi et al. |
4994079 | February 19, 1991 | Genese et al. |
5007917 | April 16, 1991 | Evans |
5010876 | April 30, 1991 | Henley et al. |
5015249 | May 14, 1991 | Nakao et al. |
5020514 | June 4, 1991 | Heckele |
5020535 | June 4, 1991 | Parker et al. |
5025778 | June 25, 1991 | Silverstein et al. |
5026379 | June 25, 1991 | Yoon |
5033169 | July 23, 1991 | Bindon |
5037433 | August 6, 1991 | Wilk et al. |
5041129 | August 20, 1991 | Hayhurst et al. |
5046513 | September 10, 1991 | Gatturna et al. |
5049153 | September 17, 1991 | Nakao et al. |
5050585 | September 24, 1991 | Takahashi |
5052372 | October 1, 1991 | Shapiro |
5065516 | November 19, 1991 | Dulebohn |
5066295 | November 19, 1991 | Kozak et al. |
5098378 | March 24, 1992 | Piontek et al. |
5099827 | March 31, 1992 | Melzer et al. |
5108421 | April 28, 1992 | Fowler |
5123913 | June 23, 1992 | Wilk et al. |
5123914 | June 23, 1992 | Cope |
5133727 | July 28, 1992 | Bales et al. |
5147374 | September 15, 1992 | Fernandez |
5156609 | October 20, 1992 | Nakao et al. |
5174300 | December 29, 1992 | Bales et al. |
5176126 | January 5, 1993 | Chikama |
5190050 | March 2, 1993 | Nitzsche |
5190555 | March 2, 1993 | Wetter et al. |
5192284 | March 9, 1993 | Pleatman |
5192300 | March 9, 1993 | Fowler |
5197963 | March 30, 1993 | Parins |
5201752 | April 13, 1993 | Brown et al. |
5201908 | April 13, 1993 | Jones |
5203785 | April 20, 1993 | Slater |
5203787 | April 20, 1993 | Noblitt et al. |
5209747 | May 11, 1993 | Knoepfler |
5217003 | June 8, 1993 | Wilk |
5217453 | June 8, 1993 | Wilk |
5219357 | June 15, 1993 | Honkanen et al. |
5219358 | June 15, 1993 | Bendel et al. |
5222362 | June 29, 1993 | Maus et al. |
5222961 | June 29, 1993 | Nakao et al. |
5222965 | June 29, 1993 | Haughton |
5234437 | August 10, 1993 | Sepetka |
5234453 | August 10, 1993 | Smith et al. |
5235964 | August 17, 1993 | Abenaim |
5242456 | September 7, 1993 | Nash et al. |
5245460 | September 14, 1993 | Allen et al. |
5246424 | September 21, 1993 | Wilk |
5257999 | November 2, 1993 | Slanetz, Jr. |
5259366 | November 9, 1993 | Reydel et al. |
5263958 | November 23, 1993 | deGuillebon et al. |
5273524 | December 28, 1993 | Fox et al. |
5275607 | January 4, 1994 | Lo et al. |
5275614 | January 4, 1994 | Haber et al. |
5275616 | January 4, 1994 | Fowler |
5284128 | February 8, 1994 | Hart |
5284162 | February 8, 1994 | Wilk |
5287845 | February 22, 1994 | Faul et al. |
5287852 | February 22, 1994 | Arkinstall |
5290299 | March 1, 1994 | Fain et al. |
5290302 | March 1, 1994 | Pericic |
5295977 | March 22, 1994 | Cohen et al. |
5297536 | March 29, 1994 | Wilk |
5297687 | March 29, 1994 | Freed |
5301061 | April 5, 1994 | Nakada et al. |
5312023 | May 17, 1994 | Green et al. |
5312333 | May 17, 1994 | Churinetz et al. |
5312351 | May 17, 1994 | Gerrone |
5312416 | May 17, 1994 | Spaeth et al. |
5312423 | May 17, 1994 | Rosenbluth et al. |
5318589 | June 7, 1994 | Lichtman |
5320636 | June 14, 1994 | Slater |
5324261 | June 28, 1994 | Amundson et al. |
5325845 | July 5, 1994 | Adair |
5330471 | July 19, 1994 | Eggers |
5330486 | July 19, 1994 | Wilk |
5330488 | July 19, 1994 | Goldrath |
5330496 | July 19, 1994 | Alferness |
5330502 | July 19, 1994 | Hassler et al. |
5331971 | July 26, 1994 | Bales et al. |
5334168 | August 2, 1994 | Hemmer |
5334198 | August 2, 1994 | Hart et al. |
5336192 | August 9, 1994 | Palestrant |
5336222 | August 9, 1994 | Durgin, Jr. et al. |
5339805 | August 23, 1994 | Parker |
5341815 | August 30, 1994 | Cofone et al. |
5342396 | August 30, 1994 | Cook |
5344428 | September 6, 1994 | Griffiths |
5345927 | September 13, 1994 | Bonutti |
5348259 | September 20, 1994 | Blanco et al. |
5350391 | September 27, 1994 | Iacovelli |
5352184 | October 4, 1994 | Goldberg et al. |
5352222 | October 4, 1994 | Rydell |
5354302 | October 11, 1994 | Ko |
5354311 | October 11, 1994 | Kambin et al. |
5356381 | October 18, 1994 | Ensminger et al. |
5356408 | October 18, 1994 | Rydell |
5360428 | November 1, 1994 | Hutchinson, Jr. |
5364408 | November 15, 1994 | Gordon |
5364410 | November 15, 1994 | Failla et al. |
5366466 | November 22, 1994 | Christian et al. |
5366467 | November 22, 1994 | Lynch et al. |
5368605 | November 29, 1994 | Miller, Jr. |
5368606 | November 29, 1994 | Marlow et al. |
5370647 | December 6, 1994 | Graber et al. |
5370679 | December 6, 1994 | Atlee, III |
5374273 | December 20, 1994 | Nakao et al. |
5374275 | December 20, 1994 | Bradley et al. |
5374277 | December 20, 1994 | Hassler |
5374953 | December 20, 1994 | Sasaki et al. |
5376077 | December 27, 1994 | Gomringer |
5377695 | January 3, 1995 | An Haack |
5378234 | January 3, 1995 | Hammerslag et al. |
5383877 | January 24, 1995 | Clarke |
5383888 | January 24, 1995 | Zvenyatsky et al. |
5386817 | February 7, 1995 | Jones |
5387259 | February 7, 1995 | Davidson |
5391174 | February 21, 1995 | Weston |
5392789 | February 28, 1995 | Slater et al. |
5395367 | March 7, 1995 | Wilk |
5395381 | March 7, 1995 | Green et al. |
5395386 | March 7, 1995 | Slater |
5397332 | March 14, 1995 | Kammerer et al. |
5401248 | March 28, 1995 | Bencini |
5403311 | April 4, 1995 | Abele et al. |
5403326 | April 4, 1995 | Harrison et al. |
5403328 | April 4, 1995 | Shallman |
5403342 | April 4, 1995 | Tovey et al. |
5403348 | April 4, 1995 | Bonutti |
5405073 | April 11, 1995 | Porter |
5405359 | April 11, 1995 | Pierce |
5409478 | April 25, 1995 | Gerry et al. |
5417699 | May 23, 1995 | Klein et al. |
5423821 | June 13, 1995 | Pasque |
5431635 | July 11, 1995 | Yoon |
5433721 | July 18, 1995 | Hooven et al. |
5433735 | July 18, 1995 | Zanakis et al. |
5439471 | August 8, 1995 | Kerr |
5439478 | August 8, 1995 | Palmer |
5441059 | August 15, 1995 | Dannan |
5441494 | August 15, 1995 | Ortiz |
5441498 | August 15, 1995 | Perkins |
5441499 | August 15, 1995 | Fritzsch |
5443463 | August 22, 1995 | Stern et al. |
5445638 | August 29, 1995 | Rydell et al. |
5445648 | August 29, 1995 | Cook |
5449021 | September 12, 1995 | Chikama |
5454827 | October 3, 1995 | Aust et al. |
5456667 | October 10, 1995 | Ham et al. |
5456684 | October 10, 1995 | Schmidt et al. |
5458131 | October 17, 1995 | Wilk |
5458583 | October 17, 1995 | McNeely et al. |
5460168 | October 24, 1995 | Masubuchi et al. |
5460629 | October 24, 1995 | Shlain et al. |
5462561 | October 31, 1995 | Voda |
5465731 | November 14, 1995 | Bell et al. |
5467763 | November 21, 1995 | McMahon et al. |
5468250 | November 21, 1995 | Paraschac et al. |
5470308 | November 28, 1995 | Edwards et al. |
5470320 | November 28, 1995 | Tiefenbrun et al. |
5472441 | December 5, 1995 | Edwards et al. |
5478347 | December 26, 1995 | Aranyi |
5478352 | December 26, 1995 | Fowler |
5480404 | January 2, 1996 | Kammerer et al. |
5482029 | January 9, 1996 | Sekiguchi et al. |
5482054 | January 9, 1996 | Slater et al. |
5484451 | January 16, 1996 | Akopov et al. |
5489256 | February 6, 1996 | Adair |
5496347 | March 5, 1996 | Hashiguchi et al. |
5499990 | March 19, 1996 | Schülken et al. |
5499992 | March 19, 1996 | Meade et al. |
5499997 | March 19, 1996 | Sharpe et al. |
5500012 | March 19, 1996 | Brucker et al. |
5501692 | March 26, 1996 | Riza |
5503616 | April 2, 1996 | Jones |
5505686 | April 9, 1996 | Willis et al. |
5507755 | April 16, 1996 | Gresl et al. |
5511564 | April 30, 1996 | Wilk |
5514157 | May 7, 1996 | Nicholas et al. |
5518501 | May 21, 1996 | Oneda et al. |
5522829 | June 4, 1996 | Michalos |
5522830 | June 4, 1996 | Aranyi |
5527321 | June 18, 1996 | Hinchliffe |
5533418 | July 9, 1996 | Wu et al. |
5536234 | July 16, 1996 | Newman |
5536248 | July 16, 1996 | Weaver et al. |
5538509 | July 23, 1996 | Dunlap et al. |
5540648 | July 30, 1996 | Yoon |
5549637 | August 27, 1996 | Crainich |
5554151 | September 10, 1996 | Hinchliffe |
5555883 | September 17, 1996 | Avitall |
5558133 | September 24, 1996 | Bortoli et al. |
5562693 | October 8, 1996 | Devlin et al. |
5569243 | October 29, 1996 | Kortenbach et al. |
5569298 | October 29, 1996 | Schnell |
5571090 | November 5, 1996 | Sherts |
5573540 | November 12, 1996 | Yoon |
5578030 | November 26, 1996 | Levin |
5582611 | December 10, 1996 | Tsuruta et al. |
5582617 | December 10, 1996 | Klieman et al. |
5584845 | December 17, 1996 | Hart |
5590660 | January 7, 1997 | MacAulay et al. |
5591179 | January 7, 1997 | Edelstein |
5591205 | January 7, 1997 | Fowler |
5593420 | January 14, 1997 | Eubanks, Jr. et al. |
5595562 | January 21, 1997 | Grier |
5597378 | January 28, 1997 | Jervis |
5601573 | February 11, 1997 | Fogelberg et al. |
5601574 | February 11, 1997 | Stefanchik et al. |
5601588 | February 11, 1997 | Tonomura et al. |
5601602 | February 11, 1997 | Fowler |
5604531 | February 18, 1997 | Iddan et al. |
5607386 | March 4, 1997 | Flam |
5607389 | March 4, 1997 | Edwards et al. |
5607406 | March 4, 1997 | Hernandez et al. |
5607450 | March 4, 1997 | Zvenyatsky et al. |
5609601 | March 11, 1997 | Kolesa et al. |
5613975 | March 25, 1997 | Christy |
5613977 | March 25, 1997 | Weber et al. |
5614943 | March 25, 1997 | Nakamura et al. |
5616117 | April 1, 1997 | Dinkier et al. |
5618303 | April 8, 1997 | Marlow et al. |
5620415 | April 15, 1997 | Lucey et al. |
5624399 | April 29, 1997 | Ackerman |
5624431 | April 29, 1997 | Gerry et al. |
5626578 | May 6, 1997 | Tihon |
5626587 | May 6, 1997 | Bishop et al. |
5628732 | May 13, 1997 | Antoon, Jr. et al. |
5630782 | May 20, 1997 | Adair |
5630795 | May 20, 1997 | Kuramoto et al. |
5643283 | July 1, 1997 | Younker |
5643292 | July 1, 1997 | Hart |
5643294 | July 1, 1997 | Tovey et al. |
5644798 | July 8, 1997 | Shah |
5645083 | July 8, 1997 | Essig et al. |
5645519 | July 8, 1997 | Lee et al. |
5645565 | July 8, 1997 | Rudd et al. |
5649372 | July 22, 1997 | Souza |
5653677 | August 5, 1997 | Okada et al. |
5653690 | August 5, 1997 | Booth et al. |
5653722 | August 5, 1997 | Kieturakis |
5657755 | August 19, 1997 | Desai |
5662621 | September 2, 1997 | Lafontaine |
5662663 | September 2, 1997 | Shallman |
5667527 | September 16, 1997 | Cook |
5669875 | September 23, 1997 | van Eerdenburg |
5681276 | October 28, 1997 | Lundquist |
5681279 | October 28, 1997 | Roper et al. |
5681324 | October 28, 1997 | Kammerer et al. |
5681330 | October 28, 1997 | Hughett et al. |
5685820 | November 11, 1997 | Riek et al. |
5690606 | November 25, 1997 | Slotman |
5690656 | November 25, 1997 | Cope et al. |
5690660 | November 25, 1997 | Kauker et al. |
5695448 | December 9, 1997 | Kimura et al. |
5695505 | December 9, 1997 | Yoon |
5695511 | December 9, 1997 | Cano et al. |
5700275 | December 23, 1997 | Bell et al. |
5702438 | December 30, 1997 | Avitall |
5704892 | January 6, 1998 | Adair |
5709708 | January 20, 1998 | Thal |
5711921 | January 27, 1998 | Langford |
5716326 | February 10, 1998 | Dannan |
5716375 | February 10, 1998 | Fowler |
5725542 | March 10, 1998 | Yoon |
5728094 | March 17, 1998 | Edwards |
5730740 | March 24, 1998 | Wales et al. |
5735849 | April 7, 1998 | Baden et al. |
5741234 | April 21, 1998 | Aboul-Hosn |
5741278 | April 21, 1998 | Stevens |
5741285 | April 21, 1998 | McBrayer et al. |
5741429 | April 21, 1998 | Donadio, III et al. |
5743456 | April 28, 1998 | Jones et al. |
5746759 | May 5, 1998 | Meade et al. |
5749826 | May 12, 1998 | Faulkner |
5749881 | May 12, 1998 | Sackier et al. |
5749889 | May 12, 1998 | Bacich et al. |
5752951 | May 19, 1998 | Yanik |
5755731 | May 26, 1998 | Grinberg |
5759150 | June 2, 1998 | Konou et al. |
5759151 | June 2, 1998 | Sturges |
5762604 | June 9, 1998 | Kieturakis |
5766167 | June 16, 1998 | Eggers et al. |
5766170 | June 16, 1998 | Eggers |
5766205 | June 16, 1998 | Zvenyatsky et al. |
5769849 | June 23, 1998 | Eggers |
5776188 | July 7, 1998 | Shepherd et al. |
5779701 | July 14, 1998 | McBrayer et al. |
5779716 | July 14, 1998 | Cano et al. |
5779720 | July 14, 1998 | Walder-Utz et al. |
5779727 | July 14, 1998 | Orejola |
5782859 | July 21, 1998 | Nicholas et al. |
5782861 | July 21, 1998 | Cragg et al. |
5782866 | July 21, 1998 | Wenstrom, Jr. |
5791022 | August 11, 1998 | Bohman |
5792113 | August 11, 1998 | Kramer et al. |
5792153 | August 11, 1998 | Swain et al. |
5792165 | August 11, 1998 | Klieman et al. |
5797835 | August 25, 1998 | Green |
5797928 | August 25, 1998 | Kogasaka |
5797939 | August 25, 1998 | Yoon |
5797941 | August 25, 1998 | Schulze et al. |
5797959 | August 25, 1998 | Castro et al. |
5797960 | August 25, 1998 | Stevens et al. |
5800449 | September 1, 1998 | Wales |
5800451 | September 1, 1998 | Buess et al. |
5803903 | September 8, 1998 | Athas et al. |
5807395 | September 15, 1998 | Mulier et al. |
5808665 | September 15, 1998 | Green |
5810805 | September 22, 1998 | Sutcu et al. |
5810806 | September 22, 1998 | Ritchart et al. |
5810849 | September 22, 1998 | Kontos |
5810865 | September 22, 1998 | Koscher et al. |
5810876 | September 22, 1998 | Kelleher |
5810877 | September 22, 1998 | Roth et al. |
5813976 | September 29, 1998 | Filipi et al. |
5814026 | September 29, 1998 | Yoon |
5814058 | September 29, 1998 | Carlson et al. |
5817061 | October 6, 1998 | Goodwin et al. |
5817107 | October 6, 1998 | Schaller |
5817119 | October 6, 1998 | Klieman et al. |
5818527 | October 6, 1998 | Yamaguchi et al. |
5819736 | October 13, 1998 | Avny et al. |
5823947 | October 20, 1998 | Yoon et al. |
5824071 | October 20, 1998 | Nelson et al. |
5827190 | October 27, 1998 | Palcic et al. |
5827276 | October 27, 1998 | LeVeen et al. |
5827281 | October 27, 1998 | Levin |
5827299 | October 27, 1998 | Thomason et al. |
5827323 | October 27, 1998 | Klieman et al. |
5830221 | November 3, 1998 | Stein et al. |
5830231 | November 3, 1998 | Geiges, Jr. |
5833603 | November 10, 1998 | Kovacs et al. |
5833700 | November 10, 1998 | Fogelberg et al. |
5833703 | November 10, 1998 | Manushakian |
5833715 | November 10, 1998 | Vachon et al. |
5836960 | November 17, 1998 | Kolesa et al. |
5843017 | December 1, 1998 | Yoon |
5843097 | December 1, 1998 | Mayenberger et al. |
5843121 | December 1, 1998 | Yoon |
5849022 | December 15, 1998 | Sakashita et al. |
5853374 | December 29, 1998 | Hart et al. |
5855569 | January 5, 1999 | Komi |
5855585 | January 5, 1999 | Kontos |
5860913 | January 19, 1999 | Yamaya et al. |
5860995 | January 19, 1999 | Berkelaar |
5868762 | February 9, 1999 | Cragg et al. |
5873849 | February 23, 1999 | Bernard |
5876411 | March 2, 1999 | Kontos |
5882331 | March 16, 1999 | Sasaki |
5882344 | March 16, 1999 | Stouder, Jr. |
5893846 | April 13, 1999 | Bales et al. |
5893874 | April 13, 1999 | Bourque et al. |
5893875 | April 13, 1999 | O'Connor et al. |
5897487 | April 27, 1999 | Ouchi |
5899919 | May 4, 1999 | Eubanks, Jr. et al. |
5902238 | May 11, 1999 | Golden et al. |
5902254 | May 11, 1999 | Magram |
5904702 | May 18, 1999 | Ek et al. |
5906625 | May 25, 1999 | Bito et al. |
5908420 | June 1, 1999 | Parins et al. |
5908429 | June 1, 1999 | Yoon |
5911737 | June 15, 1999 | Lee et al. |
5916146 | June 29, 1999 | Allotta et al. |
5916147 | June 29, 1999 | Boury |
5919207 | July 6, 1999 | Taheri |
5921892 | July 13, 1999 | Easton |
5921993 | July 13, 1999 | Yoon |
5921997 | July 13, 1999 | Fogelberg et al. |
5922008 | July 13, 1999 | Gimpelson |
5925052 | July 20, 1999 | Simmons |
5928255 | July 27, 1999 | Meade et al. |
5928266 | July 27, 1999 | Kontos |
5936536 | August 10, 1999 | Morris |
5938661 | August 17, 1999 | Hahnen |
5941815 | August 24, 1999 | Chang |
5944718 | August 31, 1999 | Austin et al. |
5951547 | September 14, 1999 | Gough et al. |
5951549 | September 14, 1999 | Richardson et al. |
5954720 | September 21, 1999 | Wilson et al. |
5954731 | September 21, 1999 | Yoon |
5957936 | September 28, 1999 | Yoon et al. |
5957943 | September 28, 1999 | Vaitekunas |
5957953 | September 28, 1999 | DiPoto et al. |
5964782 | October 12, 1999 | Lafontaine et al. |
5970581 | October 26, 1999 | Chadwick et al. |
5971995 | October 26, 1999 | Rousseau |
5972002 | October 26, 1999 | Bark et al. |
5976074 | November 2, 1999 | Moriyama |
5976075 | November 2, 1999 | Beane et al. |
5976130 | November 2, 1999 | McBrayer et al. |
5976131 | November 2, 1999 | Guglielmi et al. |
5980539 | November 9, 1999 | Kontos |
5980556 | November 9, 1999 | Giordano et al. |
5984933 | November 16, 1999 | Yoon |
5984938 | November 16, 1999 | Yoon |
5984939 | November 16, 1999 | Yoon |
5984950 | November 16, 1999 | Cragg et al. |
5989182 | November 23, 1999 | Hori et al. |
5993447 | November 30, 1999 | Blewett et al. |
5993474 | November 30, 1999 | Ouchi |
5995875 | November 30, 1999 | Blewett et al. |
5997555 | December 7, 1999 | Kontos |
6001120 | December 14, 1999 | Levin |
6004269 | December 21, 1999 | Crowley et al. |
6004330 | December 21, 1999 | Middleman et al. |
6007566 | December 28, 1999 | Wenstrom, Jr. |
6010515 | January 4, 2000 | Swain et al. |
6012494 | January 11, 2000 | Balazs |
6016452 | January 18, 2000 | Kasevich |
6017356 | January 25, 2000 | Frederick et al. |
6019770 | February 1, 2000 | Christoudias |
6024708 | February 15, 2000 | Bales et al. |
6024747 | February 15, 2000 | Kontos |
6027522 | February 22, 2000 | Palmer |
6030365 | February 29, 2000 | Laufer |
6030384 | February 29, 2000 | Nezhat |
6030634 | February 29, 2000 | Wu et al. |
6033399 | March 7, 2000 | Gines |
6033401 | March 7, 2000 | Edwards et al. |
6036640 | March 14, 2000 | Corace et al. |
6036685 | March 14, 2000 | Mueller |
6050992 | April 18, 2000 | Nichols |
6053927 | April 25, 2000 | Hamas |
6053937 | April 25, 2000 | Edwards et al. |
6059719 | May 9, 2000 | Yamamoto et al. |
6066160 | May 23, 2000 | Colvin et al. |
6068603 | May 30, 2000 | Suzuki |
6068629 | May 30, 2000 | Haissaguerre et al. |
6071233 | June 6, 2000 | Ishikawa et al. |
6074408 | June 13, 2000 | Freeman |
6086530 | July 11, 2000 | Mack |
6086600 | July 11, 2000 | Kortenbach |
6090105 | July 18, 2000 | Zepeda et al. |
6090108 | July 18, 2000 | McBrayer et al. |
6090129 | July 18, 2000 | Ouchi |
6096046 | August 1, 2000 | Weiss |
6102909 | August 15, 2000 | Chen et al. |
6102926 | August 15, 2000 | Tartaglia et al. |
6106473 | August 22, 2000 | Violante et al. |
6106521 | August 22, 2000 | Blewett et al. |
6109852 | August 29, 2000 | Shahinpoor et al. |
6110154 | August 29, 2000 | Shimomura et al. |
6110183 | August 29, 2000 | Cope |
6113593 | September 5, 2000 | Tu et al. |
6117144 | September 12, 2000 | Nobles et al. |
6117158 | September 12, 2000 | Measamer et al. |
6123718 | September 26, 2000 | Tu et al. |
6131790 | October 17, 2000 | Piraka |
6139555 | October 31, 2000 | Hart et al. |
6141037 | October 31, 2000 | Upton et al. |
6146391 | November 14, 2000 | Cigaina |
6148222 | November 14, 2000 | Ramsey, III |
6149653 | November 21, 2000 | Deslauriers |
6149662 | November 21, 2000 | Pugliesi et al. |
6152871 | November 28, 2000 | Foley et al. |
6152920 | November 28, 2000 | Thompson et al. |
6156006 | December 5, 2000 | Brosens et al. |
6159200 | December 12, 2000 | Verdura et al. |
6165175 | December 26, 2000 | Wampler et al. |
6165184 | December 26, 2000 | Verdura et al. |
6168570 | January 2, 2001 | Ferrera |
6168605 | January 2, 2001 | Measamer et al. |
6169269 | January 2, 2001 | Maynard |
6170130 | January 9, 2001 | Hamilton et al. |
6173872 | January 16, 2001 | Cohen |
6179776 | January 30, 2001 | Adams et al. |
6179832 | January 30, 2001 | Jones et al. |
6179837 | January 30, 2001 | Hooven |
6183420 | February 6, 2001 | Douk et al. |
6190353 | February 20, 2001 | Makower et al. |
6190383 | February 20, 2001 | Schmaltz et al. |
6190384 | February 20, 2001 | Ouchi |
6190399 | February 20, 2001 | Palmer et al. |
6203533 | March 20, 2001 | Ouchi |
6206872 | March 27, 2001 | Lafond et al. |
6206877 | March 27, 2001 | Kese et al. |
6206904 | March 27, 2001 | Ouchi |
6210409 | April 3, 2001 | Ellman et al. |
6214007 | April 10, 2001 | Anderson |
6214028 | April 10, 2001 | Yoon et al. |
6216043 | April 10, 2001 | Swanson et al. |
6228096 | May 8, 2001 | Marchand |
6231506 | May 15, 2001 | Hu et al. |
6234958 | May 22, 2001 | Snoke et al. |
6240312 | May 29, 2001 | Alfano et al. |
6245079 | June 12, 2001 | Nobles et al. |
6246914 | June 12, 2001 | de la Rama et al. |
6248124 | June 19, 2001 | Pedros et al. |
6258064 | July 10, 2001 | Smith et al. |
6261242 | July 17, 2001 | Roberts et al. |
6264664 | July 24, 2001 | Avellanet |
6270497 | August 7, 2001 | Sekino et al. |
6270505 | August 7, 2001 | Yoshida et al. |
6277136 | August 21, 2001 | Bonutti |
6283963 | September 4, 2001 | Regula |
6287304 | September 11, 2001 | Eggers et al. |
6293909 | September 25, 2001 | Chu et al. |
6293952 | September 25, 2001 | Brosens et al. |
6296630 | October 2, 2001 | Altman et al. |
6314963 | November 13, 2001 | Vaska et al. |
6322578 | November 27, 2001 | Houle et al. |
6325534 | December 4, 2001 | Hawley et al. |
6326177 | December 4, 2001 | Schoenbach et al. |
6328730 | December 11, 2001 | Harkrider, Jr. |
6350267 | February 26, 2002 | Stefanchik |
6350269 | February 26, 2002 | Shipp et al. |
6350278 | February 26, 2002 | Lenker et al. |
6352503 | March 5, 2002 | Matsui et al. |
6352541 | March 5, 2002 | Kienzle et al. |
6352543 | March 5, 2002 | Cole |
6355013 | March 12, 2002 | van Muiden |
6355035 | March 12, 2002 | Manushakian |
6361534 | March 26, 2002 | Chen et al. |
6364879 | April 2, 2002 | Chen et al. |
6368340 | April 9, 2002 | Malecki et al. |
6371956 | April 16, 2002 | Wilson et al. |
6379366 | April 30, 2002 | Fleischman et al. |
6383195 | May 7, 2002 | Richard |
6383197 | May 7, 2002 | Conlon et al. |
6387671 | May 14, 2002 | Rubinsky et al. |
6391029 | May 21, 2002 | Hooven et al. |
6398708 | June 4, 2002 | Hastings et al. |
6402735 | June 11, 2002 | Langevin |
6402746 | June 11, 2002 | Whayne et al. |
6406440 | June 18, 2002 | Stefanchik |
6409727 | June 25, 2002 | Bales et al. |
6409733 | June 25, 2002 | Conlon et al. |
6419639 | July 16, 2002 | Walther et al. |
6419641 | July 16, 2002 | Mark et al. |
6427089 | July 30, 2002 | Knowlton |
6431500 | August 13, 2002 | Jacobs et al. |
6436107 | August 20, 2002 | Wang et al. |
6443970 | September 3, 2002 | Schulze et al. |
6443988 | September 3, 2002 | Felt et al. |
6447444 | September 10, 2002 | Avni et al. |
6447511 | September 10, 2002 | Slater |
6447523 | September 10, 2002 | Middleman et al. |
6454783 | September 24, 2002 | Piskun |
6454785 | September 24, 2002 | De Hoyos Garza |
6458074 | October 1, 2002 | Matsui et al. |
6458076 | October 1, 2002 | Pruitt |
6464701 | October 15, 2002 | Hooven et al. |
6464702 | October 15, 2002 | Schulze et al. |
6470218 | October 22, 2002 | Behl |
6475104 | November 5, 2002 | Lutz et al. |
6485411 | November 26, 2002 | Konstorum et al. |
6489745 | December 3, 2002 | Koreis |
6491626 | December 10, 2002 | Stone et al. |
6491627 | December 10, 2002 | Komi |
6491691 | December 10, 2002 | Morley et al. |
6493590 | December 10, 2002 | Wessman et al. |
6494893 | December 17, 2002 | Dubrul et al. |
6500176 | December 31, 2002 | Truckai et al. |
6503192 | January 7, 2003 | Ouchi |
6506190 | January 14, 2003 | Walshe |
6508827 | January 21, 2003 | Manhes |
6514239 | February 4, 2003 | Shimmura et al. |
6517534 | February 11, 2003 | McGovern et al. |
6520954 | February 18, 2003 | Ouchi |
6526320 | February 25, 2003 | Mitchell |
6527753 | March 4, 2003 | Sekine et al. |
6527782 | March 4, 2003 | Hogg et al. |
6530880 | March 11, 2003 | Pagliuca |
6530922 | March 11, 2003 | Cosman et al. |
6535764 | March 18, 2003 | Imran et al. |
6537200 | March 25, 2003 | Leysieffer et al. |
6543456 | April 8, 2003 | Freeman |
6551270 | April 22, 2003 | Bimbo et al. |
6551356 | April 22, 2003 | Rousseau |
6554766 | April 29, 2003 | Maeda et al. |
6554823 | April 29, 2003 | Palmer et al. |
6554829 | April 29, 2003 | Schulze et al. |
6558384 | May 6, 2003 | Mayenberger |
6562034 | May 13, 2003 | Edwards et al. |
6562035 | May 13, 2003 | Levin |
6562052 | May 13, 2003 | Nobles et al. |
6569120 | May 27, 2003 | Green et al. |
6569159 | May 27, 2003 | Edwards et al. |
6572629 | June 3, 2003 | Kalloo et al. |
6572635 | June 3, 2003 | Bonutti |
6575988 | June 10, 2003 | Rousseau |
6579311 | June 17, 2003 | Makower |
6581889 | June 24, 2003 | Carpenter et al. |
6585642 | July 1, 2003 | Christopher |
6585717 | July 1, 2003 | Wittenberger et al. |
6587750 | July 1, 2003 | Gerbi et al. |
6592559 | July 15, 2003 | Pakter et al. |
6592603 | July 15, 2003 | Lasner |
6594971 | July 22, 2003 | Addy et al. |
6602262 | August 5, 2003 | Griego et al. |
6605105 | August 12, 2003 | Cuschieri et al. |
6610072 | August 26, 2003 | Christy et al. |
6610074 | August 26, 2003 | Santilli |
6613038 | September 2, 2003 | Bonutti et al. |
6613068 | September 2, 2003 | Ouchi |
6616632 | September 9, 2003 | Sharp et al. |
6620193 | September 16, 2003 | Lau et al. |
6623448 | September 23, 2003 | Slater |
6626919 | September 30, 2003 | Swanstrom |
6632171 | October 14, 2003 | Iddan et al. |
6632229 | October 14, 2003 | Yamanouchi |
6632234 | October 14, 2003 | Kieturakis et al. |
6638275 | October 28, 2003 | McGaffigan et al. |
6638286 | October 28, 2003 | Burbank et al. |
6645225 | November 11, 2003 | Atkinson |
6652518 | November 25, 2003 | Wellman et al. |
6652521 | November 25, 2003 | Schulze |
6652545 | November 25, 2003 | Shipp et al. |
6652551 | November 25, 2003 | Heiss |
6656194 | December 2, 2003 | Gannoe et al. |
6663641 | December 16, 2003 | Kovac et al. |
6663655 | December 16, 2003 | Ginn et al. |
6666854 | December 23, 2003 | Lange |
6672338 | January 6, 2004 | Esashi et al. |
6673058 | January 6, 2004 | Snow |
6673070 | January 6, 2004 | Edwards et al. |
6673087 | January 6, 2004 | Chang et al. |
6673092 | January 6, 2004 | Bacher |
6676685 | January 13, 2004 | Pedros et al. |
6679882 | January 20, 2004 | Kornerup |
6684938 | February 3, 2004 | Tsujita et al. |
6685628 | February 3, 2004 | Vu |
6685724 | February 3, 2004 | Haluck |
6692445 | February 17, 2004 | Roberts et al. |
6692462 | February 17, 2004 | Mackenzie et al. |
6692493 | February 17, 2004 | McGovern et al. |
6695867 | February 24, 2004 | Ginn et al. |
6699180 | March 2, 2004 | Kobayashi |
6699256 | March 2, 2004 | Logan et al. |
6699263 | March 2, 2004 | Cope |
6706018 | March 16, 2004 | Westlund et al. |
6708066 | March 16, 2004 | Herbst et al. |
6709188 | March 23, 2004 | Ushimaru |
6709445 | March 23, 2004 | Boebel et al. |
6716226 | April 6, 2004 | Sixto, Jr. et al. |
6731875 | May 4, 2004 | Kartalopoulos |
6736822 | May 18, 2004 | McClellan et al. |
6740030 | May 25, 2004 | Martone et al. |
6740082 | May 25, 2004 | Shadduck |
6743166 | June 1, 2004 | Berci et al. |
6743226 | June 1, 2004 | Cosman et al. |
6743239 | June 1, 2004 | Kuehn et al. |
6743240 | June 1, 2004 | Smith et al. |
6749560 | June 15, 2004 | Konstorum et al. |
6749609 | June 15, 2004 | Lunsford et al. |
6752768 | June 22, 2004 | Burdorff et al. |
6752811 | June 22, 2004 | Chu et al. |
6752822 | June 22, 2004 | Jespersen |
6758857 | July 6, 2004 | Cioanta et al. |
6761685 | July 13, 2004 | Adams et al. |
6761718 | July 13, 2004 | Madsen |
6761722 | July 13, 2004 | Cole et al. |
6767356 | July 27, 2004 | Kanner et al. |
6773434 | August 10, 2004 | Ciarrocca |
6776165 | August 17, 2004 | Jin |
6776787 | August 17, 2004 | Phung et al. |
6780151 | August 24, 2004 | Grabover et al. |
6780352 | August 24, 2004 | Jacobson |
6783491 | August 31, 2004 | Saadat et al. |
6786382 | September 7, 2004 | Hoffman |
6786864 | September 7, 2004 | Matsuura et al. |
6786905 | September 7, 2004 | Swanson et al. |
6788977 | September 7, 2004 | Fenn et al. |
6790173 | September 14, 2004 | Saadat et al. |
6790217 | September 14, 2004 | Schulze et al. |
6795728 | September 21, 2004 | Chornenky et al. |
6800056 | October 5, 2004 | Tartaglia et al. |
6808491 | October 26, 2004 | Kortenbach et al. |
6817974 | November 16, 2004 | Cooper et al. |
6818007 | November 16, 2004 | Dampney et al. |
6821285 | November 23, 2004 | Laufer et al. |
6824548 | November 30, 2004 | Smith et al. |
6830545 | December 14, 2004 | Bendall |
6835200 | December 28, 2004 | Laufer et al. |
6836688 | December 28, 2004 | Ingle et al. |
6837847 | January 4, 2005 | Ewers et al. |
6840246 | January 11, 2005 | Downing |
6840938 | January 11, 2005 | Morley et al. |
6843794 | January 18, 2005 | Sixto, Jr. et al. |
6861250 | March 1, 2005 | Cole et al. |
6866627 | March 15, 2005 | Nozue |
6866628 | March 15, 2005 | Goodman et al. |
6869394 | March 22, 2005 | Ishibiki |
6878106 | April 12, 2005 | Herrmann |
6878110 | April 12, 2005 | Yang et al. |
6881213 | April 19, 2005 | Ryan et al. |
6881216 | April 19, 2005 | Di Caprio et al. |
6884213 | April 26, 2005 | Raz et al. |
6887255 | May 3, 2005 | Shimm |
6889089 | May 3, 2005 | Behl et al. |
6890295 | May 10, 2005 | Michels et al. |
6896683 | May 24, 2005 | Gadberry et al. |
6896692 | May 24, 2005 | Ginn et al. |
6899710 | May 31, 2005 | Hooven |
6908427 | June 21, 2005 | Fleener et al. |
6908476 | June 21, 2005 | Jud et al. |
6913613 | July 5, 2005 | Schwarz et al. |
6916284 | July 12, 2005 | Moriyama |
6918871 | July 19, 2005 | Schulze |
6918906 | July 19, 2005 | Long |
6918908 | July 19, 2005 | Bonner et al. |
6926723 | August 9, 2005 | Mulhauser et al. |
6926725 | August 9, 2005 | Cooke et al. |
6932810 | August 23, 2005 | Ryan |
6932824 | August 23, 2005 | Roop et al. |
6932827 | August 23, 2005 | Cole |
6932834 | August 23, 2005 | Lizardi et al. |
6936003 | August 30, 2005 | Iddan |
6939290 | September 6, 2005 | Iddan |
6939292 | September 6, 2005 | Mizuno |
6939327 | September 6, 2005 | Hall et al. |
6939347 | September 6, 2005 | Thompson |
6942613 | September 13, 2005 | Ewers et al. |
6944490 | September 13, 2005 | Chow |
6945472 | September 20, 2005 | Wuttke et al. |
6945979 | September 20, 2005 | Kortenbach et al. |
6949096 | September 27, 2005 | Davison et al. |
6955641 | October 18, 2005 | Lubock |
6955683 | October 18, 2005 | Bonutti |
6958035 | October 25, 2005 | Friedman et al. |
6960162 | November 1, 2005 | Saadat et al. |
6960163 | November 1, 2005 | Ewers et al. |
6960183 | November 1, 2005 | Nicolette |
6962587 | November 8, 2005 | Johnson et al. |
6964662 | November 15, 2005 | Kidooka |
6966909 | November 22, 2005 | Marshall et al. |
6966919 | November 22, 2005 | Sixto, Jr. et al. |
6967462 | November 22, 2005 | Landis |
6971988 | December 6, 2005 | Orban, III |
6972017 | December 6, 2005 | Smith et al. |
6974411 | December 13, 2005 | Belson |
6976992 | December 20, 2005 | Sachatello et al. |
6984203 | January 10, 2006 | Tartaglia et al. |
6984205 | January 10, 2006 | Gazdzinski |
6986738 | January 17, 2006 | Glukhovsky et al. |
6986774 | January 17, 2006 | Middleman et al. |
6988987 | January 24, 2006 | Ishikawa et al. |
6989028 | January 24, 2006 | Lashinski et al. |
6991602 | January 31, 2006 | Nakazawa et al. |
6991627 | January 31, 2006 | Madhani et al. |
6991631 | January 31, 2006 | Woloszko et al. |
6994706 | February 7, 2006 | Chornenky et al. |
6994708 | February 7, 2006 | Manzo |
6997870 | February 14, 2006 | Couvillon, Jr. |
6997931 | February 14, 2006 | Sauer et al. |
7000818 | February 21, 2006 | Shelton, IV et al. |
7001329 | February 21, 2006 | Kobayashi et al. |
7001341 | February 21, 2006 | Gellman et al. |
7008375 | March 7, 2006 | Weisel |
7008419 | March 7, 2006 | Shadduck |
7009634 | March 7, 2006 | Iddan et al. |
7010340 | March 7, 2006 | Scarantino et al. |
7011669 | March 14, 2006 | Kimblad |
7018373 | March 28, 2006 | Suzuki |
7020531 | March 28, 2006 | Colliou et al. |
7025580 | April 11, 2006 | Heagy et al. |
7025721 | April 11, 2006 | Cohen et al. |
7029435 | April 18, 2006 | Nakao |
7029438 | April 18, 2006 | Morin et al. |
7029450 | April 18, 2006 | Gellman |
7032600 | April 25, 2006 | Fukuda et al. |
7035680 | April 25, 2006 | Partridge et al. |
7037290 | May 2, 2006 | Gardeski et al. |
7041052 | May 9, 2006 | Saadat et al. |
7052454 | May 30, 2006 | Taylor |
7052489 | May 30, 2006 | Griego et al. |
7056330 | June 6, 2006 | Gayton |
7060024 | June 13, 2006 | Long et al. |
7060025 | June 13, 2006 | Long et al. |
7063697 | June 20, 2006 | Slater |
7063715 | June 20, 2006 | Onuki et al. |
7066879 | June 27, 2006 | Fowler et al. |
7066936 | June 27, 2006 | Ryan |
7070559 | July 4, 2006 | Adams et al. |
7070602 | July 4, 2006 | Smith et al. |
7076305 | July 11, 2006 | Imran et al. |
7083618 | August 1, 2006 | Couture et al. |
7083620 | August 1, 2006 | Jahns et al. |
7083629 | August 1, 2006 | Weller et al. |
7083635 | August 1, 2006 | Ginn |
7087010 | August 8, 2006 | Ootawara et al. |
7087071 | August 8, 2006 | Nicholas et al. |
7088923 | August 8, 2006 | Haruyama |
7090673 | August 15, 2006 | Dycus et al. |
7090683 | August 15, 2006 | Brock et al. |
7090685 | August 15, 2006 | Kortenbach et al. |
7093518 | August 22, 2006 | Gmeilbauer |
7101371 | September 5, 2006 | Dycus et al. |
7101372 | September 5, 2006 | Dycus et al. |
7101373 | September 5, 2006 | Dycus et al. |
7105000 | September 12, 2006 | McBrayer |
7105005 | September 12, 2006 | Blake |
7108696 | September 19, 2006 | Daniel et al. |
7108703 | September 19, 2006 | Danitz et al. |
7112208 | September 26, 2006 | Morris et al. |
7115092 | October 3, 2006 | Park et al. |
7115124 | October 3, 2006 | Xiao |
7115785 | October 3, 2006 | Guggenheim et al. |
7117703 | October 10, 2006 | Kato et al. |
7118531 | October 10, 2006 | Krill |
7118578 | October 10, 2006 | West, Jr. et al. |
7118587 | October 10, 2006 | Dycus et al. |
7122605 | October 17, 2006 | Ohrbom et al. |
7128708 | October 31, 2006 | Saadat et al. |
7130697 | October 31, 2006 | Chornenky et al. |
RE39415 | November 28, 2006 | Bales et al. |
7131978 | November 7, 2006 | Sancoff et al. |
7131979 | November 7, 2006 | DiCarlo et al. |
7131980 | November 7, 2006 | Field et al. |
7137980 | November 21, 2006 | Buysse et al. |
7137981 | November 21, 2006 | Long |
7146984 | December 12, 2006 | Stack et al. |
7147650 | December 12, 2006 | Lee |
7150097 | December 19, 2006 | Sremcich et al. |
7150655 | December 19, 2006 | Mastrototaro et al. |
7150750 | December 19, 2006 | Damarati |
7152488 | December 26, 2006 | Hedrich et al. |
7153321 | December 26, 2006 | Andrews |
7156845 | January 2, 2007 | Mulier et al. |
7160296 | January 9, 2007 | Pearson et al. |
7163525 | January 16, 2007 | Franer |
7169104 | January 30, 2007 | Ueda et al. |
7172714 | February 6, 2007 | Jacobson |
7175591 | February 13, 2007 | Kaladelfos |
7179254 | February 20, 2007 | Pendekanti et al. |
7186265 | March 6, 2007 | Sharkawy et al. |
7188627 | March 13, 2007 | Nelson et al. |
7195612 | March 27, 2007 | Van Sloten et al. |
7195631 | March 27, 2007 | Dumbauld |
7204820 | April 17, 2007 | Akahoshi |
7204840 | April 17, 2007 | Skakoon et al. |
7207997 | April 24, 2007 | Shipp et al. |
7208005 | April 24, 2007 | Frecker et al. |
7211089 | May 1, 2007 | Kear et al. |
7211092 | May 1, 2007 | Hughett |
7220227 | May 22, 2007 | Sasaki et al. |
7223271 | May 29, 2007 | Muramatsu et al. |
7223272 | May 29, 2007 | Francere et al. |
7226458 | June 5, 2007 | Kaplan et al. |
7229438 | June 12, 2007 | Young |
7232414 | June 19, 2007 | Gonzalez |
7232445 | June 19, 2007 | Kortenbach et al. |
7235084 | June 26, 2007 | Skakoon et al. |
7235089 | June 26, 2007 | McGuckin, Jr. |
7241290 | July 10, 2007 | Doyle et al. |
7241295 | July 10, 2007 | Maguire |
7244228 | July 17, 2007 | Lubowski |
7250027 | July 31, 2007 | Barry |
7252660 | August 7, 2007 | Kunz |
7255675 | August 14, 2007 | Gertner et al. |
7261725 | August 28, 2007 | Binmoeller |
7270663 | September 18, 2007 | Nakao |
7288075 | October 30, 2007 | Parihar et al. |
7290615 | November 6, 2007 | Christanti et al. |
7291127 | November 6, 2007 | Eidenschink |
7294139 | November 13, 2007 | Gengler |
7301250 | November 27, 2007 | Cassel |
7306597 | December 11, 2007 | Manzo |
7308828 | December 18, 2007 | Hashimoto |
7311107 | December 25, 2007 | Harel et al. |
7318802 | January 15, 2008 | Suzuki et al. |
7320695 | January 22, 2008 | Carroll |
7322934 | January 29, 2008 | Miyake et al. |
7323006 | January 29, 2008 | Andreas et al. |
7329256 | February 12, 2008 | Johnson et al. |
7329257 | February 12, 2008 | Kanehira et al. |
7329383 | February 12, 2008 | Stinson |
7335220 | February 26, 2008 | Khosravi et al. |
7341554 | March 11, 2008 | Sekine et al. |
7344536 | March 18, 2008 | Lunsford et al. |
7349223 | March 25, 2008 | Haemer et al. |
7352387 | April 1, 2008 | Yamamoto |
7364582 | April 29, 2008 | Lee |
7371215 | May 13, 2008 | Colliou et al. |
7381216 | June 3, 2008 | Buzzard et al. |
7390324 | June 24, 2008 | Whalen et al. |
7393322 | July 1, 2008 | Wenchell |
7402162 | July 22, 2008 | Ouchi |
7404791 | July 29, 2008 | Linares et al. |
7410483 | August 12, 2008 | Danitz et al. |
7413563 | August 19, 2008 | Corcoran et al. |
7416554 | August 26, 2008 | Lam et al. |
7422590 | September 9, 2008 | Kupferschmid et al. |
7435229 | October 14, 2008 | Wolf |
7435257 | October 14, 2008 | Lashinski et al. |
7441507 | October 28, 2008 | Teraura et al. |
7442166 | October 28, 2008 | Huang et al. |
7452327 | November 18, 2008 | Durgin et al. |
7455208 | November 25, 2008 | Wales et al. |
7455675 | November 25, 2008 | Schur et al. |
7468066 | December 23, 2008 | Vargas et al. |
7476237 | January 13, 2009 | Taniguchi et al. |
7479104 | January 20, 2009 | Lau et al. |
7485093 | February 3, 2009 | Glukhovsky |
7488295 | February 10, 2009 | Burbank et al. |
7494499 | February 24, 2009 | Nagase et al. |
7497867 | March 3, 2009 | Lasner et al. |
7498950 | March 3, 2009 | Ertas et al. |
7507200 | March 24, 2009 | Okada |
7507239 | March 24, 2009 | Shadduck |
7510107 | March 31, 2009 | Timm et al. |
7511733 | March 31, 2009 | Takizawa et al. |
7514568 | April 7, 2009 | Freeman |
7515953 | April 7, 2009 | Madar et al. |
7520876 | April 21, 2009 | Ressemann et al. |
7524281 | April 28, 2009 | Chu et al. |
7524302 | April 28, 2009 | Tower |
7534228 | May 19, 2009 | Williams |
7535570 | May 19, 2009 | Muraishi |
7540872 | June 2, 2009 | Schechter et al. |
7542807 | June 2, 2009 | Bertolero et al. |
7544203 | June 9, 2009 | Chin et al. |
7548040 | June 16, 2009 | Lee et al. |
7549564 | June 23, 2009 | Boudreaux |
7549991 | June 23, 2009 | Lu et al. |
7549998 | June 23, 2009 | Braun |
7553278 | June 30, 2009 | Kucklick |
7553298 | June 30, 2009 | Hunt et al. |
7559452 | July 14, 2009 | Wales et al. |
7559887 | July 14, 2009 | Dannan |
7559916 | July 14, 2009 | Smith et al. |
7560006 | July 14, 2009 | Rakos et al. |
7561907 | July 14, 2009 | Fuimaono et al. |
7561916 | July 14, 2009 | Hunt et al. |
7565201 | July 21, 2009 | Blackmore et al. |
7566334 | July 28, 2009 | Christian et al. |
7575144 | August 18, 2009 | Ortiz et al. |
7575548 | August 18, 2009 | Takemoto et al. |
7579005 | August 25, 2009 | Keeler et al. |
7579550 | August 25, 2009 | Dayton et al. |
7582096 | September 1, 2009 | Gellman et al. |
7588177 | September 15, 2009 | Racenet |
7588557 | September 15, 2009 | Nakao |
7591781 | September 22, 2009 | Hirata |
7597229 | October 6, 2009 | Boudreaux et al. |
7604150 | October 20, 2009 | Boudreaux |
7608083 | October 27, 2009 | Lee et al. |
7611479 | November 3, 2009 | Cragg et al. |
7612084 | November 3, 2009 | James et al. |
7615002 | November 10, 2009 | Rothweiler et al. |
7615005 | November 10, 2009 | Stefanchik et al. |
7618398 | November 17, 2009 | Holman et al. |
7621936 | November 24, 2009 | Cragg et al. |
7632250 | December 15, 2009 | Smith et al. |
7635373 | December 22, 2009 | Ortiz |
7637903 | December 29, 2009 | Lentz et al. |
7648519 | January 19, 2010 | Lee et al. |
7650742 | January 26, 2010 | Ushijima |
7651483 | January 26, 2010 | Byrum et al. |
7651509 | January 26, 2010 | Bojarski et al. |
7653438 | January 26, 2010 | Deem et al. |
7654431 | February 2, 2010 | Hueil et al. |
7655004 | February 2, 2010 | Long |
7662089 | February 16, 2010 | Okada et al. |
7666180 | February 23, 2010 | Holsten et al. |
7666203 | February 23, 2010 | Chanduszko et al. |
7670282 | March 2, 2010 | Mathis |
7670336 | March 2, 2010 | Young et al. |
7674259 | March 9, 2010 | Shadduck |
7678043 | March 16, 2010 | Gilad |
7680543 | March 16, 2010 | Azure |
7684599 | March 23, 2010 | Horn et al. |
7684851 | March 23, 2010 | Miyake et al. |
7686826 | March 30, 2010 | Lee et al. |
7697970 | April 13, 2010 | Uchiyama et al. |
7699835 | April 20, 2010 | Lee et al. |
7699864 | April 20, 2010 | Kick et al. |
7710563 | May 4, 2010 | Betzig et al. |
7713189 | May 11, 2010 | Hanke |
7713270 | May 11, 2010 | Suzuki |
7721742 | May 25, 2010 | Kalloo et al. |
7722631 | May 25, 2010 | Mikkaichi et al. |
7736374 | June 15, 2010 | Vaughan et al. |
7744613 | June 29, 2010 | Ewers et al. |
7744615 | June 29, 2010 | Couture |
7749161 | July 6, 2010 | Beckman et al. |
7751866 | July 6, 2010 | Aoki et al. |
7753901 | July 13, 2010 | Piskun et al. |
7753933 | July 13, 2010 | Ginn et al. |
7758577 | July 20, 2010 | Nobis et al. |
7762949 | July 27, 2010 | Nakao |
7762998 | July 27, 2010 | Birk et al. |
7763012 | July 27, 2010 | Petrick et al. |
7765010 | July 27, 2010 | Chornenky et al. |
7766896 | August 3, 2010 | Kornkven Volk et al. |
7770584 | August 10, 2010 | Danek et al. |
7771416 | August 10, 2010 | Spivey et al. |
7771437 | August 10, 2010 | Hogg et al. |
7776035 | August 17, 2010 | Rick et al. |
7780683 | August 24, 2010 | Roue et al. |
7780691 | August 24, 2010 | Stefanchik |
7784663 | August 31, 2010 | Shelton, IV |
7794409 | September 14, 2010 | Damarati |
7794447 | September 14, 2010 | Dann et al. |
7794458 | September 14, 2010 | McIntyre et al. |
7794475 | September 14, 2010 | Hess et al. |
7798386 | September 21, 2010 | Schall et al. |
7798750 | September 21, 2010 | Clark |
7815565 | October 19, 2010 | Stefanchik et al. |
7815566 | October 19, 2010 | Stefanchik et al. |
7815651 | October 19, 2010 | Skakoon et al. |
7815659 | October 19, 2010 | Conlon et al. |
7815662 | October 19, 2010 | Spivey et al. |
7819836 | October 26, 2010 | Levine et al. |
7828186 | November 9, 2010 | Wales |
7828809 | November 9, 2010 | Skakoon et al. |
7833156 | November 16, 2010 | Williams et al. |
7833231 | November 16, 2010 | Skakoon et al. |
7833238 | November 16, 2010 | Nakao |
7837615 | November 23, 2010 | Le et al. |
7842028 | November 30, 2010 | Lee |
7842068 | November 30, 2010 | Ginn |
7846171 | December 7, 2010 | Kullas et al. |
7850660 | December 14, 2010 | Uth et al. |
7857183 | December 28, 2010 | Shelton, IV |
7857820 | December 28, 2010 | Skakoon et al. |
7862546 | January 4, 2011 | Conlon et al. |
7862553 | January 4, 2011 | Ewaschuk |
7867216 | January 11, 2011 | Wahr et al. |
7871371 | January 18, 2011 | Komiya et al. |
7879004 | February 1, 2011 | Seibel et al. |
7883458 | February 8, 2011 | Hamel |
7887530 | February 15, 2011 | Zemlok et al. |
7887558 | February 15, 2011 | Lin et al. |
7892200 | February 22, 2011 | Birk et al. |
7892220 | February 22, 2011 | Faller et al. |
7896804 | March 1, 2011 | Uchimura et al. |
7896887 | March 1, 2011 | Rimbaugh et al. |
7905828 | March 15, 2011 | Brock et al. |
7909809 | March 22, 2011 | Scopton et al. |
7914513 | March 29, 2011 | Voorhees, Jr. |
7916809 | March 29, 2011 | Tsushima |
7918785 | April 5, 2011 | Okada et al. |
7918869 | April 5, 2011 | Saadat et al. |
7922743 | April 12, 2011 | Heinrich et al. |
7927271 | April 19, 2011 | Dimitriou et al. |
7931624 | April 26, 2011 | Smith et al. |
7937143 | May 3, 2011 | Demarais et al. |
7945332 | May 17, 2011 | Schechter |
7947000 | May 24, 2011 | Vargas et al. |
7953326 | May 31, 2011 | Farr et al. |
7955298 | June 7, 2011 | Carroll et al. |
7959627 | June 14, 2011 | Utley et al. |
7959629 | June 14, 2011 | Young et al. |
7963975 | June 21, 2011 | Criscuolo |
7965180 | June 21, 2011 | Koyama |
7967808 | June 28, 2011 | Fitzgerald et al. |
7969473 | June 28, 2011 | Kotoda |
7972330 | July 5, 2011 | Alejandro et al. |
7976458 | July 12, 2011 | Stefanchik et al. |
7976552 | July 12, 2011 | Suzuki |
7985239 | July 26, 2011 | Suzuki |
7985830 | July 26, 2011 | Mance et al. |
7988618 | August 2, 2011 | Mikkaichi et al. |
7988685 | August 2, 2011 | Ziaie et al. |
8007495 | August 30, 2011 | McDaniel et al. |
8021362 | September 20, 2011 | Deem et al. |
8029504 | October 4, 2011 | Long |
8034046 | October 11, 2011 | Eidenschink |
8037591 | October 18, 2011 | Spivey et al. |
8043289 | October 25, 2011 | Behl et al. |
8048067 | November 1, 2011 | Davalos et al. |
8048108 | November 1, 2011 | Sibbitt et al. |
8052699 | November 8, 2011 | Sherwinter |
8057510 | November 15, 2011 | Ginn et al. |
8062306 | November 22, 2011 | Nobis et al. |
8062311 | November 22, 2011 | Litscher et al. |
8066632 | November 29, 2011 | Dario et al. |
8066702 | November 29, 2011 | Rittman, III et al. |
8070759 | December 6, 2011 | Stefanchik et al. |
8070804 | December 6, 2011 | Hyde et al. |
8075572 | December 13, 2011 | Stefanchik et al. |
8075587 | December 13, 2011 | Ginn |
8083787 | December 27, 2011 | Korb et al. |
8088062 | January 3, 2012 | Zwolinski |
8096459 | January 17, 2012 | Ortiz et al. |
8096941 | January 17, 2012 | Fowler et al. |
8100922 | January 24, 2012 | Griffith |
8105342 | January 31, 2012 | Onuki et al. |
8109872 | February 7, 2012 | Kennedy, II et al. |
8114072 | February 14, 2012 | Long et al. |
8114119 | February 14, 2012 | Spivey et al. |
8115447 | February 14, 2012 | Toya et al. |
8118821 | February 21, 2012 | Mouw |
8118834 | February 21, 2012 | Goraltchouk et al. |
8131371 | March 6, 2012 | Demarals et al. |
8147424 | April 3, 2012 | Kassab et al. |
8157813 | April 17, 2012 | Ko et al. |
8157834 | April 17, 2012 | Conlon |
8172772 | May 8, 2012 | Zwolinski et al. |
8182414 | May 22, 2012 | Handa et al. |
8187166 | May 29, 2012 | Kuth et al. |
8200334 | June 12, 2012 | Min et al. |
8206295 | June 26, 2012 | Kaul |
8211125 | July 3, 2012 | Spivey |
8216224 | July 10, 2012 | Morris et al. |
8221310 | July 17, 2012 | Saadat et al. |
8221411 | July 17, 2012 | Francischelli et al. |
8222385 | July 17, 2012 | Yoshizaki et al. |
8241204 | August 14, 2012 | Spivey |
8251068 | August 28, 2012 | Schnell |
8252057 | August 28, 2012 | Fox |
8262563 | September 11, 2012 | Bakos et al. |
8262655 | September 11, 2012 | Ghabrial et al. |
8262680 | September 11, 2012 | Swain et al. |
8267854 | September 18, 2012 | Asada et al. |
8303581 | November 6, 2012 | Arts et al. |
8308738 | November 13, 2012 | Nobis et al. |
8317806 | November 27, 2012 | Coe et al. |
8317814 | November 27, 2012 | Karasawa et al. |
8328836 | December 11, 2012 | Conlon et al. |
8337394 | December 25, 2012 | Vakharia |
8337492 | December 25, 2012 | Kunis et al. |
8343041 | January 1, 2013 | Byers et al. |
8353487 | January 15, 2013 | Trusty et al. |
8357170 | January 22, 2013 | Stefanchik |
8359093 | January 22, 2013 | Wariar |
8361066 | January 29, 2013 | Long et al. |
8361112 | January 29, 2013 | Carroll, II et al. |
8366733 | February 5, 2013 | Gabel et al. |
8377057 | February 19, 2013 | Rick et al. |
8403926 | March 26, 2013 | Nobis et al. |
8409200 | April 2, 2013 | Holcomb et al. |
8425505 | April 23, 2013 | Long |
8430811 | April 30, 2013 | Hess et al. |
8449452 | May 28, 2013 | Iddan et al. |
8449538 | May 28, 2013 | Long |
8454594 | June 4, 2013 | Demarais |
8475359 | July 2, 2013 | Asada et al. |
8475452 | July 2, 2013 | Van Wyk et al. |
8480657 | July 9, 2013 | Bakos |
8480689 | July 9, 2013 | Spivey et al. |
8485968 | July 16, 2013 | Weimer et al. |
8496574 | July 30, 2013 | Trusty et al. |
8500697 | August 6, 2013 | Kurth et al. |
8506564 | August 13, 2013 | Long et al. |
8512335 | August 20, 2013 | Cheng et al. |
8523884 | September 3, 2013 | Stam et al. |
8523939 | September 3, 2013 | Hausen |
8529563 | September 10, 2013 | Long et al. |
8545396 | October 1, 2013 | Cover et al. |
8568410 | October 29, 2013 | Vakharia et al. |
8579897 | November 12, 2013 | Vakharia et al. |
8608652 | December 17, 2013 | Voegele et al. |
8623011 | January 7, 2014 | Spivey |
8636648 | January 28, 2014 | Gazdzinski |
8636730 | January 28, 2014 | Keppel |
8640940 | February 4, 2014 | Ohdaira |
8652150 | February 18, 2014 | Swain et al. |
8668686 | March 11, 2014 | Govari et al. |
8679003 | March 25, 2014 | Spivey |
8685058 | April 1, 2014 | Wilk |
8727967 | May 20, 2014 | Weitzner |
8747401 | June 10, 2014 | Gonzalez et al. |
8753335 | June 17, 2014 | Moshe et al. |
8771173 | July 8, 2014 | Fonger et al. |
8771260 | July 8, 2014 | Conlon et al. |
8828031 | September 9, 2014 | Fox et al. |
8845656 | September 30, 2014 | Skakoon et al. |
8858590 | October 14, 2014 | Shelton, IV et al. |
8880185 | November 4, 2014 | Hastings et al. |
8882786 | November 11, 2014 | Bearinger et al. |
8888792 | November 18, 2014 | Harris et al. |
8906035 | December 9, 2014 | Zwolinski et al. |
8911452 | December 16, 2014 | Skakoon et al. |
8939897 | January 27, 2015 | Nobis |
8956352 | February 17, 2015 | Mauch |
8974374 | March 10, 2015 | Schostek et al. |
8986199 | March 24, 2015 | Weisenburgh, II et al. |
9005198 | April 14, 2015 | Long et al. |
9011431 | April 21, 2015 | Long et al. |
9028483 | May 12, 2015 | Long et al. |
9036015 | May 19, 2015 | Verburgh et al. |
9049987 | June 9, 2015 | Conlon et al. |
9078662 | July 14, 2015 | Bakos et al. |
9186203 | November 17, 2015 | Spivey et al. |
9248278 | February 2, 2016 | Crosby et al. |
9271796 | March 1, 2016 | Buysse et al. |
9295485 | March 29, 2016 | Conlon et al. |
9339328 | May 17, 2016 | Ortiz et al. |
9427255 | August 30, 2016 | Griffith et al. |
9668725 | June 6, 2017 | Beaven |
9788885 | October 17, 2017 | Long et al. |
9788888 | October 17, 2017 | Bakos et al. |
9861272 | January 9, 2018 | Pell et al. |
9883910 | February 6, 2018 | Conlon et al. |
10004558 | June 26, 2018 | Long et al. |
20010023333 | September 20, 2001 | Wise et al. |
20020022771 | February 21, 2002 | Diokno et al. |
20020022857 | February 21, 2002 | Goldsteen et al. |
20020023353 | February 28, 2002 | Ting-Kung |
20020029055 | March 7, 2002 | Bonutti |
20020042562 | April 11, 2002 | Meron et al. |
20020049439 | April 25, 2002 | Muller et al. |
20020068945 | June 6, 2002 | Sixto, Jr. et al. |
20020078967 | June 27, 2002 | Sixto, Jr. et al. |
20020082516 | June 27, 2002 | Stefanchik |
20020082551 | June 27, 2002 | Yachia et al. |
20020095164 | July 18, 2002 | Andreas et al. |
20020107530 | August 8, 2002 | Sauer et al. |
20020133115 | September 19, 2002 | Gordon et al. |
20020138086 | September 26, 2002 | Sixto, Jr. et al. |
20020147456 | October 10, 2002 | Diduch et al. |
20020165592 | November 7, 2002 | Glukhovsky et al. |
20020173805 | November 21, 2002 | Matsuno et al. |
20020183591 | December 5, 2002 | Matsuura et al. |
20030014090 | January 16, 2003 | Abrahamson |
20030018373 | January 23, 2003 | Eckhardt et al. |
20030023255 | January 30, 2003 | Miles et al. |
20030036679 | February 20, 2003 | Kortenbach et al. |
20030069602 | April 10, 2003 | Jacobs et al. |
20030078471 | April 24, 2003 | Foley et al. |
20030083681 | May 1, 2003 | Moutafis et al. |
20030114731 | June 19, 2003 | Cadeddu et al. |
20030114732 | June 19, 2003 | Webler et al. |
20030120257 | June 26, 2003 | Houston et al. |
20030124009 | July 3, 2003 | Ravi et al. |
20030125770 | July 3, 2003 | Fuimaono |
20030130564 | July 10, 2003 | Martone et al. |
20030130656 | July 10, 2003 | Levin |
20030139646 | July 24, 2003 | Sharrow et al. |
20030158521 | August 21, 2003 | Ameri |
20030167062 | September 4, 2003 | Gambale et al. |
20030171651 | September 11, 2003 | Page et al. |
20030176880 | September 18, 2003 | Long et al. |
20030187351 | October 2, 2003 | Franck et al. |
20030216611 | November 20, 2003 | Vu |
20030216615 | November 20, 2003 | Ouchi |
20030220545 | November 27, 2003 | Ouchi |
20030225312 | December 4, 2003 | Suzuki et al. |
20030225332 | December 4, 2003 | Okada et al. |
20030229269 | December 11, 2003 | Humphrey |
20030229371 | December 11, 2003 | Whitworth |
20030236549 | December 25, 2003 | Bonadio et al. |
20040002683 | January 1, 2004 | Nicholson et al. |
20040024414 | February 5, 2004 | Downing |
20040034369 | February 19, 2004 | Sauer et al. |
20040054322 | March 18, 2004 | Vargas |
20040098007 | May 20, 2004 | Heiss |
20040101456 | May 27, 2004 | Kuroshima et al. |
20040104999 | June 3, 2004 | Okada |
20040116948 | June 17, 2004 | Sixto, Jr. et al. |
20040127940 | July 1, 2004 | Ginn et al. |
20040133077 | July 8, 2004 | Obenchain et al. |
20040133089 | July 8, 2004 | Kilcoyne et al. |
20040136779 | July 15, 2004 | Bhaskar |
20040138525 | July 15, 2004 | Saadat et al. |
20040138529 | July 15, 2004 | Wiltshire et al. |
20040138587 | July 15, 2004 | Lyons, IV |
20040138747 | July 15, 2004 | Kaladelfos |
20040161451 | August 19, 2004 | Pierce et al. |
20040167545 | August 26, 2004 | Sadler et al. |
20040176699 | September 9, 2004 | Walker et al. |
20040186350 | September 23, 2004 | Brenneman et al. |
20040193009 | September 30, 2004 | Jaffe et al. |
20040193146 | September 30, 2004 | Lee et al. |
20040193186 | September 30, 2004 | Kortenbach et al. |
20040193188 | September 30, 2004 | Francese |
20040193189 | September 30, 2004 | Kortenbach et al. |
20040193200 | September 30, 2004 | Dworschak et al. |
20040199052 | October 7, 2004 | Banik et al. |
20040199159 | October 7, 2004 | Lee et al. |
20040206859 | October 21, 2004 | Chong et al. |
20040210245 | October 21, 2004 | Erickson et al. |
20040215058 | October 28, 2004 | Zirps et al. |
20040225183 | November 11, 2004 | Michlitsch et al. |
20040225186 | November 11, 2004 | Horne, Jr. et al. |
20040225323 | November 11, 2004 | Nagase et al. |
20040230095 | November 18, 2004 | Stefanchik et al. |
20040230096 | November 18, 2004 | Stefanchik et al. |
20040230161 | November 18, 2004 | Zeiner |
20040243108 | December 2, 2004 | Suzuki |
20040249246 | December 9, 2004 | Campos |
20040249367 | December 9, 2004 | Saadat et al. |
20040249394 | December 9, 2004 | Morris et al. |
20040249443 | December 9, 2004 | Shanley et al. |
20040254572 | December 16, 2004 | McIntyre et al. |
20040260198 | December 23, 2004 | Rothberg et al. |
20040260315 | December 23, 2004 | Dell et al. |
20040260337 | December 23, 2004 | Freed |
20050004515 | January 6, 2005 | Hart et al. |
20050033265 | February 10, 2005 | Engel et al. |
20050033277 | February 10, 2005 | Clague et al. |
20050033319 | February 10, 2005 | Gambale et al. |
20050033333 | February 10, 2005 | Smith et al. |
20050043690 | February 24, 2005 | Todd |
20050049616 | March 3, 2005 | Rivera et al. |
20050059963 | March 17, 2005 | Phan et al. |
20050059964 | March 17, 2005 | Fitz |
20050065397 | March 24, 2005 | Saadat et al. |
20050065509 | March 24, 2005 | Coldwell et al. |
20050065517 | March 24, 2005 | Chin |
20050070754 | March 31, 2005 | Nobis et al. |
20050070763 | March 31, 2005 | Nobis et al. |
20050070764 | March 31, 2005 | Nobis et al. |
20050070947 | March 31, 2005 | Franer et al. |
20050080413 | April 14, 2005 | Canady |
20050080435 | April 14, 2005 | Smith et al. |
20050085693 | April 21, 2005 | Belson et al. |
20050085832 | April 21, 2005 | Sancoff et al. |
20050090837 | April 28, 2005 | Sixto, Jr. et al. |
20050090838 | April 28, 2005 | Sixto, Jr. et al. |
20050096502 | May 5, 2005 | Khalili |
20050101837 | May 12, 2005 | Kalloo et al. |
20050101838 | May 12, 2005 | Camillocci et al. |
20050101984 | May 12, 2005 | Chanduszko et al. |
20050107663 | May 19, 2005 | Saadat et al. |
20050107664 | May 19, 2005 | Kalloo et al. |
20050110881 | May 26, 2005 | Glukhovsky et al. |
20050113847 | May 26, 2005 | Gadberry et al. |
20050119613 | June 2, 2005 | Moenning et al. |
20050124855 | June 9, 2005 | Jaffe et al. |
20050125010 | June 9, 2005 | Smith et al. |
20050131279 | June 16, 2005 | Boulais et al. |
20050131457 | June 16, 2005 | Douglas et al. |
20050137454 | June 23, 2005 | Saadat et al. |
20050143647 | June 30, 2005 | Minai et al. |
20050143690 | June 30, 2005 | High |
20050143774 | June 30, 2005 | Polo |
20050143803 | June 30, 2005 | Watson et al. |
20050149087 | July 7, 2005 | Ahlberg et al. |
20050149096 | July 7, 2005 | Hilal et al. |
20050159648 | July 21, 2005 | Freed |
20050165272 | July 28, 2005 | Okada et al. |
20050165378 | July 28, 2005 | Heinrich et al. |
20050165411 | July 28, 2005 | Orban, III |
20050165429 | July 28, 2005 | Douglas et al. |
20050182429 | August 18, 2005 | Yamanouchi |
20050192478 | September 1, 2005 | Williams et al. |
20050192598 | September 1, 2005 | Johnson et al. |
20050192602 | September 1, 2005 | Manzo |
20050192654 | September 1, 2005 | Chanduszko et al. |
20050209624 | September 22, 2005 | Vijay |
20050215858 | September 29, 2005 | Vail, III |
20050216036 | September 29, 2005 | Nakao |
20050216050 | September 29, 2005 | Sepetka et al. |
20050228224 | October 13, 2005 | Okada et al. |
20050228406 | October 13, 2005 | Bose |
20050234297 | October 20, 2005 | Devierre et al. |
20050240249 | October 27, 2005 | Tu et al. |
20050250983 | November 10, 2005 | Tremaglio et al. |
20050250987 | November 10, 2005 | Ewers et al. |
20050250990 | November 10, 2005 | Le et al. |
20050250993 | November 10, 2005 | Jaeger |
20050251166 | November 10, 2005 | Vaughan et al. |
20050251176 | November 10, 2005 | Swanstrom et al. |
20050261674 | November 24, 2005 | Nobis et al. |
20050261711 | November 24, 2005 | Okada et al. |
20050267492 | December 1, 2005 | Poncet et al. |
20050272975 | December 8, 2005 | McWeeney et al. |
20050272977 | December 8, 2005 | Saadat et al. |
20050273084 | December 8, 2005 | Hinman et al. |
20050274935 | December 15, 2005 | Nelson |
20050277945 | December 15, 2005 | Saadat et al. |
20050277951 | December 15, 2005 | Smith et al. |
20050277952 | December 15, 2005 | Arp et al. |
20050277954 | December 15, 2005 | Smith et al. |
20050277955 | December 15, 2005 | Palmer et al. |
20050277956 | December 15, 2005 | Francese et al. |
20050277957 | December 15, 2005 | Kuhns et al. |
20050283118 | December 22, 2005 | Uth et al. |
20050283119 | December 22, 2005 | Uth et al. |
20050288555 | December 29, 2005 | Binmoeller |
20060004406 | January 5, 2006 | Wehrstein et al. |
20060004409 | January 5, 2006 | Nobis et al. |
20060004410 | January 5, 2006 | Nobis et al. |
20060015009 | January 19, 2006 | Jaffe et al. |
20060015131 | January 19, 2006 | Kierce et al. |
20060020167 | January 26, 2006 | Sitzmann |
20060020247 | January 26, 2006 | Kagan et al. |
20060025654 | February 2, 2006 | Suzuki et al. |
20060025781 | February 2, 2006 | Young et al. |
20060025812 | February 2, 2006 | Shelton, IV |
20060025819 | February 2, 2006 | Nobis et al. |
20060036267 | February 16, 2006 | Saadat et al. |
20060041188 | February 23, 2006 | Dirusso et al. |
20060058582 | March 16, 2006 | Maahs et al. |
20060058776 | March 16, 2006 | Bilsbury |
20060064083 | March 23, 2006 | Khalaj et al. |
20060069396 | March 30, 2006 | Meade et al. |
20060069424 | March 30, 2006 | Acosta et al. |
20060069425 | March 30, 2006 | Hillis et al. |
20060069429 | March 30, 2006 | Spence et al. |
20060074413 | April 6, 2006 | Behzadian |
20060079890 | April 13, 2006 | Guerra |
20060089528 | April 27, 2006 | Tartaglia et al. |
20060095031 | May 4, 2006 | Ormsby |
20060095060 | May 4, 2006 | Mayenberger et al. |
20060100687 | May 11, 2006 | Fahey et al. |
20060106423 | May 18, 2006 | Weisel et al. |
20060111209 | May 25, 2006 | Hinman et al. |
20060111210 | May 25, 2006 | Hinman et al. |
20060111703 | May 25, 2006 | Kunis et al. |
20060111704 | May 25, 2006 | Brenneman et al. |
20060129166 | June 15, 2006 | Lavelle |
20060135962 | June 22, 2006 | Kick et al. |
20060135971 | June 22, 2006 | Swanstrom et al. |
20060135984 | June 22, 2006 | Kramer et al. |
20060142644 | June 29, 2006 | Mulac et al. |
20060142652 | June 29, 2006 | Keenan |
20060142790 | June 29, 2006 | Gertner |
20060142798 | June 29, 2006 | Holman et al. |
20060149129 | July 6, 2006 | Watts et al. |
20060149131 | July 6, 2006 | Or |
20060149132 | July 6, 2006 | Iddan |
20060149135 | July 6, 2006 | Paz |
20060161190 | July 20, 2006 | Gadberry et al. |
20060167416 | July 27, 2006 | Mathis et al. |
20060167482 | July 27, 2006 | Swain et al. |
20060178560 | August 10, 2006 | Saadat et al. |
20060183975 | August 17, 2006 | Saadat et al. |
20060184161 | August 17, 2006 | Maahs et al. |
20060189844 | August 24, 2006 | Tien |
20060189845 | August 24, 2006 | Maahs et al. |
20060190027 | August 24, 2006 | Downey |
20060195084 | August 31, 2006 | Slater |
20060200005 | September 7, 2006 | Bjork et al. |
20060200121 | September 7, 2006 | Mowery |
20060200169 | September 7, 2006 | Sniffin |
20060200170 | September 7, 2006 | Aranyi |
20060200199 | September 7, 2006 | Bonutti et al. |
20060217665 | September 28, 2006 | Prosek |
20060217697 | September 28, 2006 | Lau et al. |
20060217742 | September 28, 2006 | Messerly et al. |
20060217743 | September 28, 2006 | Messerly et al. |
20060229639 | October 12, 2006 | Whitfield |
20060229640 | October 12, 2006 | Whitfield |
20060237022 | October 26, 2006 | Chen et al. |
20060237023 | October 26, 2006 | Cox et al. |
20060241570 | October 26, 2006 | Wilk |
20060241691 | October 26, 2006 | Wilk |
20060247500 | November 2, 2006 | Voegele et al. |
20060247576 | November 2, 2006 | Poncet |
20060247663 | November 2, 2006 | Schwartz et al. |
20060247673 | November 2, 2006 | Voegele et al. |
20060253004 | November 9, 2006 | Frisch et al. |
20060253039 | November 9, 2006 | McKenna et al. |
20060258907 | November 16, 2006 | Stefanchik et al. |
20060258908 | November 16, 2006 | Stefanchik et al. |
20060258910 | November 16, 2006 | Stefanchik et al. |
20060258954 | November 16, 2006 | Timberlake et al. |
20060258955 | November 16, 2006 | Hoffman et al. |
20060259010 | November 16, 2006 | Stefanchik et al. |
20060259073 | November 16, 2006 | Miyamoto et al. |
20060264752 | November 23, 2006 | Rubinsky et al. |
20060264904 | November 23, 2006 | Kerby et al. |
20060264930 | November 23, 2006 | Nishimura |
20060270902 | November 30, 2006 | Igarashi et al. |
20060271042 | November 30, 2006 | Latterell et al. |
20060271102 | November 30, 2006 | Bosshard et al. |
20060276835 | December 7, 2006 | Uchida |
20060281970 | December 14, 2006 | Stokes et al. |
20060282106 | December 14, 2006 | Cole et al. |
20060285732 | December 21, 2006 | Horn et al. |
20060287644 | December 21, 2006 | Inganas et al. |
20060287666 | December 21, 2006 | Saadat et al. |
20060293626 | December 28, 2006 | Byrum et al. |
20070000550 | January 4, 2007 | Osinski |
20070002135 | January 4, 2007 | Glukhovsky |
20070005019 | January 4, 2007 | Okishige |
20070010801 | January 11, 2007 | Chen et al. |
20070015965 | January 18, 2007 | Cox et al. |
20070016225 | January 18, 2007 | Nakao |
20070027469 | February 1, 2007 | Smith et al. |
20070032700 | February 8, 2007 | Fowler et al. |
20070032701 | February 8, 2007 | Fowler et al. |
20070043261 | February 22, 2007 | Watanabe et al. |
20070049800 | March 1, 2007 | Boulais |
20070049902 | March 1, 2007 | Griffin et al. |
20070049968 | March 1, 2007 | Sibbit et al. |
20070051375 | March 8, 2007 | Milliman |
20070060880 | March 15, 2007 | Gregorich et al. |
20070066869 | March 22, 2007 | Hoffman |
20070067017 | March 22, 2007 | Trapp |
20070073102 | March 29, 2007 | Matsuno et al. |
20070073269 | March 29, 2007 | Becker |
20070078439 | April 5, 2007 | Grandt et al. |
20070079924 | April 12, 2007 | Saadat et al. |
20070083192 | April 12, 2007 | Welch |
20070083195 | April 12, 2007 | Werneth et al. |
20070088370 | April 19, 2007 | Kahle et al. |
20070100375 | May 3, 2007 | Mikkaichi et al. |
20070100376 | May 3, 2007 | Mikkaichi et al. |
20070106113 | May 10, 2007 | Ravo |
20070106118 | May 10, 2007 | Moriyama |
20070106317 | May 10, 2007 | Shelton, IV et al. |
20070112251 | May 17, 2007 | Nakhuda |
20070112331 | May 17, 2007 | Weber et al. |
20070112342 | May 17, 2007 | Pearson et al. |
20070112383 | May 17, 2007 | Conlon et al. |
20070112385 | May 17, 2007 | Conlon |
20070112417 | May 17, 2007 | Shanley et al. |
20070112425 | May 17, 2007 | Schaller et al. |
20070118115 | May 24, 2007 | Artale et al. |
20070123840 | May 31, 2007 | Cox |
20070129605 | June 7, 2007 | Schaaf |
20070129719 | June 7, 2007 | Kendale et al. |
20070129760 | June 7, 2007 | Demarais et al. |
20070135709 | June 14, 2007 | Rioux et al. |
20070135803 | June 14, 2007 | Belson |
20070142706 | June 21, 2007 | Matsui et al. |
20070142710 | June 21, 2007 | Yokoi et al. |
20070142779 | June 21, 2007 | Duane et al. |
20070142780 | June 21, 2007 | Van Lue |
20070154460 | July 5, 2007 | Kraft et al. |
20070156028 | July 5, 2007 | Van Lue et al. |
20070156116 | July 5, 2007 | Gonzalez |
20070156127 | July 5, 2007 | Rioux et al. |
20070161855 | July 12, 2007 | Mikkaichi et al. |
20070162101 | July 12, 2007 | Burgermeister et al. |
20070167901 | July 19, 2007 | Herrig et al. |
20070173686 | July 26, 2007 | Lin et al. |
20070173691 | July 26, 2007 | Yokoi et al. |
20070173869 | July 26, 2007 | Gannoe et al. |
20070173870 | July 26, 2007 | Zacharias |
20070173872 | July 26, 2007 | Neuenfeldt |
20070179525 | August 2, 2007 | Frecker et al. |
20070179530 | August 2, 2007 | Tieu et al. |
20070191904 | August 16, 2007 | Libbus et al. |
20070197865 | August 23, 2007 | Miyake et al. |
20070198057 | August 23, 2007 | Gelbart et al. |
20070203398 | August 30, 2007 | Bonadio et al. |
20070203487 | August 30, 2007 | Sugita |
20070208336 | September 6, 2007 | Kim et al. |
20070208364 | September 6, 2007 | Smith et al. |
20070208407 | September 6, 2007 | Gerdts et al. |
20070213754 | September 13, 2007 | Mikkaichi et al. |
20070225552 | September 27, 2007 | Segawa et al. |
20070225554 | September 27, 2007 | Maseda et al. |
20070233040 | October 4, 2007 | Macnamara et al. |
20070244356 | October 18, 2007 | Carrillo, Jr. et al. |
20070244358 | October 18, 2007 | Lee |
20070250038 | October 25, 2007 | Boulais |
20070250057 | October 25, 2007 | Nobis et al. |
20070255096 | November 1, 2007 | Stefanchik et al. |
20070255100 | November 1, 2007 | Barlow et al. |
20070255273 | November 1, 2007 | Fernandez et al. |
20070255303 | November 1, 2007 | Bakos et al. |
20070255306 | November 1, 2007 | Conlon et al. |
20070260112 | November 8, 2007 | Rahmani |
20070260117 | November 8, 2007 | Zwolinski et al. |
20070260121 | November 8, 2007 | Bakos et al. |
20070260242 | November 8, 2007 | Dycus et al. |
20070260273 | November 8, 2007 | Cropper et al. |
20070260302 | November 8, 2007 | Igaki |
20070265494 | November 15, 2007 | Leanna et al. |
20070270629 | November 22, 2007 | Charles |
20070270889 | November 22, 2007 | Conlon et al. |
20070270895 | November 22, 2007 | Nobis et al. |
20070270907 | November 22, 2007 | Stokes et al. |
20070282165 | December 6, 2007 | Hopkins et al. |
20070282371 | December 6, 2007 | Lee et al. |
20070293727 | December 20, 2007 | Goldfarb et al. |
20070299387 | December 27, 2007 | Williams et al. |
20080004650 | January 3, 2008 | George |
20080015409 | January 17, 2008 | Barlow et al. |
20080015413 | January 17, 2008 | Barlow et al. |
20080015552 | January 17, 2008 | Doyle et al. |
20080021416 | January 24, 2008 | Arai et al. |
20080022927 | January 31, 2008 | Zhang et al. |
20080027387 | January 31, 2008 | Grabinsky |
20080033244 | February 7, 2008 | Matsui et al. |
20080033451 | February 7, 2008 | Rieber et al. |
20080051629 | February 28, 2008 | Sugiyama et al. |
20080051735 | February 28, 2008 | Measamer et al. |
20080058586 | March 6, 2008 | Karpiel |
20080058854 | March 6, 2008 | Kieturakis et al. |
20080065169 | March 13, 2008 | Colliou et al. |
20080071264 | March 20, 2008 | Azure |
20080082108 | April 3, 2008 | Skakoon et al. |
20080086172 | April 10, 2008 | Martin et al. |
20080091068 | April 17, 2008 | Terliuc |
20080097159 | April 24, 2008 | Ishiguro |
20080097472 | April 24, 2008 | Agmon et al. |
20080097483 | April 24, 2008 | Ortiz et al. |
20080103527 | May 1, 2008 | Martin et al. |
20080114384 | May 15, 2008 | Chang et al. |
20080119870 | May 22, 2008 | Williams |
20080119891 | May 22, 2008 | Miles et al. |
20080125765 | May 29, 2008 | Berenshteyn et al. |
20080125774 | May 29, 2008 | Palanker et al. |
20080125796 | May 29, 2008 | Graham |
20080132892 | June 5, 2008 | Lunsford et al. |
20080139882 | June 12, 2008 | Fujimori |
20080140069 | June 12, 2008 | Filloux et al. |
20080140071 | June 12, 2008 | Vegesna |
20080147056 | June 19, 2008 | van der Weide et al. |
20080150754 | June 26, 2008 | Quendt |
20080171907 | July 17, 2008 | Long et al. |
20080177135 | July 24, 2008 | Muyari et al. |
20080188710 | August 7, 2008 | Segawa et al. |
20080188868 | August 7, 2008 | Weitzner et al. |
20080200755 | August 21, 2008 | Bakos |
20080200762 | August 21, 2008 | Stokes et al. |
20080200911 | August 21, 2008 | Long |
20080200933 | August 21, 2008 | Bakos et al. |
20080200934 | August 21, 2008 | Fox |
20080208213 | August 28, 2008 | Benjamin et al. |
20080208280 | August 28, 2008 | Lindenthaler et al. |
20080214890 | September 4, 2008 | Motai et al. |
20080221587 | September 11, 2008 | Schwartz |
20080228213 | September 18, 2008 | Blakeney et al. |
20080230972 | September 25, 2008 | Ganley |
20080234696 | September 25, 2008 | Taylor et al. |
20080243106 | October 2, 2008 | Coe et al. |
20080243148 | October 2, 2008 | Mikkaichi et al. |
20080243176 | October 2, 2008 | Weitzner et al. |
20080249567 | October 9, 2008 | Kaplan |
20080262513 | October 23, 2008 | Stahler et al. |
20080262524 | October 23, 2008 | Bangera et al. |
20080262540 | October 23, 2008 | Bangera et al. |
20080275474 | November 6, 2008 | Martin et al. |
20080275475 | November 6, 2008 | Schwemberger et al. |
20080287737 | November 20, 2008 | Dejima |
20080287801 | November 20, 2008 | Magnin et al. |
20080287983 | November 20, 2008 | Smith et al. |
20080300461 | December 4, 2008 | Shaw et al. |
20080300547 | December 4, 2008 | Bakos |
20080300571 | December 4, 2008 | LePivert |
20080306493 | December 11, 2008 | Shibata et al. |
20080309758 | December 18, 2008 | Karasawa et al. |
20080312496 | December 18, 2008 | Zwolinski |
20080312499 | December 18, 2008 | Handa et al. |
20080312500 | December 18, 2008 | Asada et al. |
20080312506 | December 18, 2008 | Spivey et al. |
20080319436 | December 25, 2008 | Daniel et al. |
20080319439 | December 25, 2008 | Ootsubu |
20090005636 | January 1, 2009 | Pang et al. |
20090030278 | January 29, 2009 | Minakuchi |
20090054728 | February 26, 2009 | Trusty |
20090062788 | March 5, 2009 | Long et al. |
20090062795 | March 5, 2009 | Vakharia et al. |
20090069634 | March 12, 2009 | Larkin |
20090076499 | March 19, 2009 | Azure |
20090078736 | March 26, 2009 | Van Lue |
20090082627 | March 26, 2009 | Karasawa et al. |
20090082776 | March 26, 2009 | Cresina |
20090082779 | March 26, 2009 | Nakao |
20090093690 | April 9, 2009 | Yoshizawa |
20090112059 | April 30, 2009 | Nobis |
20090112063 | April 30, 2009 | Bakos et al. |
20090125042 | May 14, 2009 | Mouw |
20090131751 | May 21, 2009 | Spivey et al. |
20090143639 | June 4, 2009 | Stark |
20090143649 | June 4, 2009 | Rossi |
20090143794 | June 4, 2009 | Conlon et al. |
20090143818 | June 4, 2009 | Faller et al. |
20090149710 | June 11, 2009 | Stefanchik et al. |
20090163770 | June 25, 2009 | Torrie et al. |
20090177031 | July 9, 2009 | Surti et al. |
20090177219 | July 9, 2009 | Conlon |
20090182325 | July 16, 2009 | Werneth et al. |
20090182332 | July 16, 2009 | Long et al. |
20090192344 | July 30, 2009 | Bakos et al. |
20090192534 | July 30, 2009 | Ortiz et al. |
20090198212 | August 6, 2009 | Timberlake et al. |
20090198231 | August 6, 2009 | Esser et al. |
20090198253 | August 6, 2009 | Omori |
20090209990 | August 20, 2009 | Yates et al. |
20090210000 | August 20, 2009 | Sullivan et al. |
20090216248 | August 27, 2009 | Uenohara et al. |
20090221873 | September 3, 2009 | McGrath |
20090227999 | September 10, 2009 | Willis et al. |
20090228001 | September 10, 2009 | Pacey |
20090248055 | October 1, 2009 | Spivey et al. |
20090259105 | October 15, 2009 | Miyano et al. |
20090269317 | October 29, 2009 | Davalos |
20090281559 | November 12, 2009 | Swain et al. |
20090287206 | November 19, 2009 | Jun |
20090287236 | November 19, 2009 | Bakos et al. |
20090292164 | November 26, 2009 | Yamatani |
20090292167 | November 26, 2009 | Kimoto |
20090306470 | December 10, 2009 | Karasawa et al. |
20090322864 | December 31, 2009 | Karasawa et al. |
20090326332 | December 31, 2009 | Carter |
20100010294 | January 14, 2010 | Conlon et al. |
20100010298 | January 14, 2010 | Bakos et al. |
20100010303 | January 14, 2010 | Bakos |
20100023032 | January 28, 2010 | Granja Filho |
20100030211 | February 4, 2010 | Davalos et al. |
20100036198 | February 11, 2010 | Tacchino et al. |
20100042045 | February 18, 2010 | Spivey |
20100048990 | February 25, 2010 | Bakos |
20100049223 | February 25, 2010 | Granja Filho |
20100056862 | March 4, 2010 | Bakos |
20100056864 | March 4, 2010 | Lee |
20100076451 | March 25, 2010 | Zwolinski et al. |
20100076460 | March 25, 2010 | Taylor et al. |
20100081875 | April 1, 2010 | Fowler et al. |
20100091128 | April 15, 2010 | Ogasawara et al. |
20100113872 | May 6, 2010 | Asada et al. |
20100121362 | May 13, 2010 | Clague et al. |
20100130817 | May 27, 2010 | Conlon |
20100152539 | June 17, 2010 | Ghabrial et al. |
20100152725 | June 17, 2010 | Pearson et al. |
20100152746 | June 17, 2010 | Ceniccola et al. |
20100160906 | June 24, 2010 | Jarrard |
20100191050 | July 29, 2010 | Zwolinski |
20100191267 | July 29, 2010 | Fox |
20100198149 | August 5, 2010 | Fox |
20100198248 | August 5, 2010 | Vakharia |
20100198254 | August 5, 2010 | Schaeffer |
20100210906 | August 19, 2010 | Wendlandt |
20100217367 | August 26, 2010 | Belson |
20100249700 | September 30, 2010 | Spivey |
20100256628 | October 7, 2010 | Pearson et al. |
20100261994 | October 14, 2010 | Davalos et al. |
20100268025 | October 21, 2010 | Belson |
20100286791 | November 11, 2010 | Goldsmith |
20100298642 | November 25, 2010 | Trusty et al. |
20100312056 | December 9, 2010 | Galperin et al. |
20100331622 | December 30, 2010 | Conlon |
20100331758 | December 30, 2010 | Davalos et al. |
20110077476 | March 31, 2011 | Rofougaran |
20110087224 | April 14, 2011 | Cadeddu et al. |
20110093009 | April 21, 2011 | Fox |
20110098694 | April 28, 2011 | Long |
20110098704 | April 28, 2011 | Long et al. |
20110106221 | May 5, 2011 | Neal, II et al. |
20110112434 | May 12, 2011 | Ghabrial et al. |
20110112527 | May 12, 2011 | Hamilton, Jr. et al. |
20110115891 | May 19, 2011 | Trusty |
20110152610 | June 23, 2011 | Trusty et al. |
20110152878 | June 23, 2011 | Trusty et al. |
20110152888 | June 23, 2011 | Ho et al. |
20110152923 | June 23, 2011 | Fox |
20110160514 | June 30, 2011 | Long et al. |
20110190764 | August 4, 2011 | Long et al. |
20110193948 | August 11, 2011 | Amling et al. |
20110245619 | October 6, 2011 | Holcomb |
20110282149 | November 17, 2011 | Vargas et al. |
20110284014 | November 24, 2011 | Cadeddu et al. |
20110285488 | November 24, 2011 | Scott et al. |
20120004502 | January 5, 2012 | Weitzner et al. |
20120029335 | February 2, 2012 | Sudam et al. |
20120078266 | March 29, 2012 | Tyson, Jr. |
20120088965 | April 12, 2012 | Stokes et al. |
20120089089 | April 12, 2012 | Swain et al. |
20120089093 | April 12, 2012 | Trusty |
20120101331 | April 26, 2012 | Gilad et al. |
20120101413 | April 26, 2012 | Beetel et al. |
20120109122 | May 3, 2012 | Arena et al. |
20120116155 | May 10, 2012 | Trusty |
20120116266 | May 10, 2012 | Houser et al. |
20120149981 | June 14, 2012 | Khait et al. |
20120179148 | July 12, 2012 | Conlon |
20120191075 | July 26, 2012 | Trusty |
20120191076 | July 26, 2012 | Voegele et al. |
20120197246 | August 2, 2012 | Mauch |
20120220998 | August 30, 2012 | Long et al. |
20120220999 | August 30, 2012 | Long |
20120221002 | August 30, 2012 | Long et al. |
20120289857 | November 15, 2012 | Toth et al. |
20130030430 | January 31, 2013 | Stewart et al. |
20130090666 | April 11, 2013 | Hess et al. |
20130138091 | May 30, 2013 | Coe et al. |
20130158348 | June 20, 2013 | Nobis et al. |
20130172672 | July 4, 2013 | Iddan et al. |
20130231530 | September 5, 2013 | Lien et al. |
20130245356 | September 19, 2013 | Fernandez et al. |
20130261389 | October 3, 2013 | Long |
20130267834 | October 10, 2013 | McGee |
20130331649 | December 12, 2013 | Khait et al. |
20140031813 | January 30, 2014 | Tellio et al. |
20140039492 | February 6, 2014 | Long |
20140052126 | February 20, 2014 | Long et al. |
20140052216 | February 20, 2014 | Long et al. |
20140121678 | May 1, 2014 | Trusty et al. |
20140243597 | August 28, 2014 | Weisenburgh, II et al. |
20140343360 | November 20, 2014 | Shohat et al. |
20150032132 | January 29, 2015 | Harris et al. |
20150100064 | April 9, 2015 | Skakoon et al. |
20150230858 | August 20, 2015 | Long et al. |
20160074056 | March 17, 2016 | Conlon |
20160100879 | April 14, 2016 | Long |
20160128759 | May 12, 2016 | Long et al. |
20160296280 | October 13, 2016 | Long |
20160338731 | November 24, 2016 | Griffith et al. |
20170049508 | February 23, 2017 | Long et al. |
20170086937 | March 30, 2017 | Tellio et al. |
20170119465 | May 4, 2017 | Long et al. |
20180042661 | February 15, 2018 | Long et al. |
666310 | February 1996 | AU |
3008120 | September 1980 | DE |
4323585 | January 1995 | DE |
19713797 | October 1997 | DE |
19757056 | August 2008 | DE |
102006027873 | October 2009 | DE |
0086338 | August 1983 | EP |
0286415 | October 1988 | EP |
0499491 | August 1992 | EP |
0589454 | March 1994 | EP |
0464479 | March 1995 | EP |
0529675 | February 1996 | EP |
0773003 | May 1997 | EP |
0621009 | July 1997 | EP |
0724863 | July 1999 | EP |
0760629 | November 1999 | EP |
0818974 | July 2001 | EP |
1281356 | February 2003 | EP |
0947166 | May 2003 | EP |
0836832 | December 2003 | EP |
1402837 | March 2004 | EP |
0744918 | April 2004 | EP |
0931515 | August 2004 | EP |
0941128 | October 2004 | EP |
1411843 | October 2004 | EP |
1150614 | November 2004 | EP |
1477104 | November 2004 | EP |
1481642 | December 2004 | EP |
1493391 | January 2005 | EP |
0848598 | February 2005 | EP |
1281360 | March 2005 | EP |
1568330 | August 2005 | EP |
1452143 | September 2005 | EP |
1616527 | January 2006 | EP |
1006888 | March 2006 | EP |
1629764 | March 2006 | EP |
1013229 | June 2006 | EP |
1721561 | November 2006 | EP |
1153578 | March 2007 | EP |
1334696 | March 2007 | EP |
1769766 | April 2007 | EP |
1836971 | September 2007 | EP |
1836980 | September 2007 | EP |
1854421 | November 2007 | EP |
1857061 | November 2007 | EP |
1875876 | January 2008 | EP |
1891881 | February 2008 | EP |
1902663 | March 2008 | EP |
1477106 | June 2008 | EP |
1949844 | July 2008 | EP |
1518499 | August 2008 | EP |
1582138 | September 2008 | EP |
1709918 | October 2008 | EP |
1985226 | October 2008 | EP |
1994904 | November 2008 | EP |
1707130 | December 2008 | EP |
0723462 | March 2009 | EP |
1769749 | November 2009 | EP |
2135545 | December 2009 | EP |
1493397 | September 2011 | EP |
2659847 | November 2013 | EP |
2731610 | September 1996 | FR |
330629 | June 1930 | GB |
2335860 | October 1999 | GB |
2403909 | January 2005 | GB |
2421190 | June 2006 | GB |
2443261 | April 2008 | GB |
56-46674 | April 1981 | JP |
63309252 | December 1988 | JP |
4038960 | February 1992 | JP |
H06269460 | September 1994 | JP |
8-29699 | February 1996 | JP |
H 9-75365 | March 1997 | JP |
H 10-24049 | January 1998 | JP |
3007713 | February 2000 | JP |
2000/107197 | April 2000 | JP |
2000245683 | September 2000 | JP |
2001-526072 | December 2001 | JP |
2002-369791 | December 2002 | JP |
2003-088494 | March 2003 | JP |
2003-235852 | August 2003 | JP |
2004-33525 | February 2004 | JP |
2004-065745 | March 2004 | JP |
2005-121947 | May 2005 | JP |
2005-261514 | September 2005 | JP |
2005-296063 | October 2005 | JP |
2006517843 | August 2006 | JP |
2006297005 | November 2006 | JP |
2006-343510 | December 2006 | JP |
2007-20806 | February 2007 | JP |
2007-125264 | May 2007 | JP |
2007-516792 | June 2007 | JP |
2010/503496 | February 2010 | JP |
2012515018 | July 2012 | JP |
1021295 | February 2004 | NL |
194230 | May 1967 | SU |
980703 | December 1982 | SU |
WO 84/01707 | May 1984 | WO |
WO 86/07543 | December 1986 | WO |
WO 92/13494 | August 1992 | WO |
WO 93/10850 | June 1993 | WO |
WO 93/20760 | October 1993 | WO |
WO 93/20765 | October 1993 | WO |
WO 94/22383 | October 1994 | WO |
WO 95/09666 | April 1995 | WO |
WO 96/22056 | July 1996 | WO |
WO 96/27331 | September 1996 | WO |
WO 96/39946 | December 1996 | WO |
WO 97/12557 | April 1997 | WO |
WO 98/01080 | January 1998 | WO |
WO 99/00060 | January 1999 | WO |
WO 99/09919 | March 1999 | WO |
WO 99/17661 | April 1999 | WO |
WO 99/30622 | June 1999 | WO |
WO 00/22996 | April 2000 | WO |
WO 00/35358 | June 2000 | WO |
WO 00/68665 | November 2000 | WO |
WO 01/10319 | February 2001 | WO |
WO 01/26708 | April 2001 | WO |
WO 01/41627 | June 2001 | WO |
WO 01/58360 | August 2001 | WO |
WO 02/11621 | February 2002 | WO |
WO 02/34122 | May 2002 | WO |
WO 02/094082 | November 2002 | WO |
WO 03/045260 | June 2003 | WO |
WO 03/047684 | June 2003 | WO |
WO 03/059412 | July 2003 | WO |
WO 03/078721 | September 2003 | WO |
WO 03/081761 | October 2003 | WO |
WO 03/082129 | October 2003 | WO |
WO 2004/006789 | January 2004 | WO |
WO 2004/028613 | April 2004 | WO |
WO 2004/037123 | May 2004 | WO |
WO 2004/037149 | May 2004 | WO |
WO 2004/052221 | June 2004 | WO |
WO 2004/086984 | October 2004 | WO |
WO 2005/009211 | February 2005 | WO |
WO 2005/018467 | March 2005 | WO |
WO 2005/037088 | April 2005 | WO |
WO 2005/048827 | June 2005 | WO |
WO 2005/065284 | July 2005 | WO |
WO 2005/097019 | October 2005 | WO |
WO 2005/097234 | October 2005 | WO |
WO 2005/112810 | December 2005 | WO |
WO 2005/120363 | December 2005 | WO |
WO 2005/122866 | December 2005 | WO |
WO 2006/007399 | January 2006 | WO |
WO 2006/012630 | February 2006 | WO |
WO 2006/040109 | April 2006 | WO |
WO 2006/041881 | April 2006 | WO |
WO 2006/060405 | June 2006 | WO |
WO 2006/110733 | October 2006 | WO |
WO 2006/113216 | October 2006 | WO |
WO 2007/013059 | February 2007 | WO |
WO 2007/014063 | February 2007 | WO |
WO 2007/035537 | March 2007 | WO |
WO 2007/048085 | April 2007 | WO |
WO 2007/063550 | June 2007 | WO |
WO 2007/100067 | September 2007 | WO |
WO 2007/109171 | September 2007 | WO |
WO 2007/135577 | November 2007 | WO |
WO 2007/143200 | December 2007 | WO |
WO 2007/144004 | December 2007 | WO |
WO 2008/005433 | January 2008 | WO |
WO 2008/033356 | March 2008 | WO |
WO 2008/034103 | March 2008 | WO |
WO 2008/041225 | April 2008 | WO |
WO 2008/076337 | June 2008 | WO |
WO 2008/076800 | June 2008 | WO |
WO 2008/079440 | July 2008 | WO |
WO 2008/080062 | July 2008 | WO |
WO 2008/101075 | August 2008 | WO |
WO 2008/101086 | August 2008 | WO |
WO 2008/102154 | August 2008 | WO |
WO 2008/108863 | September 2008 | WO |
WO 2008/151237 | December 2008 | WO |
WO 2009/021030 | February 2009 | WO |
WO 2009/027065 | March 2009 | WO |
WO 2009/029065 | March 2009 | WO |
WO 2009/032623 | March 2009 | WO |
WO 2009/036457 | March 2009 | WO |
WO 2009/121017 | October 2009 | WO |
WO-2009132190 | October 2009 | WO |
WO 2010/027688 | March 2010 | WO |
WO 2010/056716 | May 2010 | WO |
WO 2010/080974 | July 2010 | WO |
WO 2010/088481 | August 2010 | WO |
WO 2012/031204 | March 2012 | WO |
WO 2012/071526 | May 2012 | WO |
WO-2012068505 | May 2012 | WO |
WO 2013/044378 | April 2013 | WO |
- International Search Report for PCT/US2013/052250, dated Oct. 29, 2013 (7 pages).
- Michael S. Kavic, M.D., “Natural Orifice Translumenal Endoscopic Surgery: “NOTES””, JSLS, vol. 10, pp. 133-134 (2006).
- Ethicon, Inc., “Wound Closure Manual: Chapter 3 (The Surgical Needle),” 15 pages, (1994).
- Guido M. Sclabas, M.D., et al., “Endoluminal Methods for Gastrotomy Closure in Natural Orifice TransEnteric Surgery (NOTES),” Surgical Innovation, vol. 13, No. 1, pp. 23-30, Mar. 2006.
- Fritscher-Ravens, et al., “Transgastric Gastropexy and Hiatal Hernia Repair for GERD Under EUS Control: a Porcine Model,” Gastrointestinal Endoscopy, vol. 59, No. 1, pp. 89-95, 2004.
- Ogando, “Prototype Tools That Go With the Flow,” Design News, 2 pages, Jul. 17, 2006.
- Edd, et al., “In Vivo Results of a New Focal Tissue Ablation Technique: Irreversible Electroporation,” IEEE Trans Biomed Eng, vol. 53, pp. 1409-1415, 2006.
- Kennedy, et al., “High-Burst-Strength, Feedback-Controlled Bipolar Vessel Sealing,” Surgical Endoscopy, vol. 12, pp. 876-878 (1998).
- Collins et al., “Local Gene Therapy of Solid Tumors with GM-CSF and B7-1 Eradicates Both Treated and Distal Tumors,” Cancer Gene Therapy, vol. 13, pp. 1061-1071 (2006).
- K. Sumiyama et al., “Transesophageal Mediastinoscopy by Submucosal Endoscopy With Mucosal Flap Safety Value Technique,” Gastrointest Endosc., Apr. 2007, vol. 65(4), pp. 679-683 (Abstract).
- K. Sumiyama et al., “Submucosal Endoscopy with Mucosal Flap Safety Valve,” Gastrointest Endosc. Apr. 2007, vol. 65(4) pp. 694-695 (Abstract).
- K. Sumiyama et al., “Transgastric Cholecystectomy: Transgastric Accessibility to the Gallbladder Improved with the SEMF Method and a Novel Multibending Therapeutic Endoscope,” Gastrointest Endosc., Jun. 2007, vol. 65(7), pp. 1028-1034 (Abstract).
- K. Sumiyama et al., “Endoscopic Caps,” Tech. Gastrointest. Endosc., vol. 8, pp. 28-32, 2006.
- “Z-Offset Technique Used in the Introduction of Trocar During Laparoscopic Surgery,” M.S. Hershey NOTES Presentation to EES NOTES Development Team, Sep. 27, 2007.
- F.N. Denans, Nouveau Procede Pour La Guerison Des Plaies Des Intestines. Extrait Des Seances De La Societe Royale De Medecine De Marseille, Pendant Le Mois De Decembre 1825, et le Premier Tremestre De 1826, Séance Du 24 Fevrier 1826. Recueil De La Societe Royale De Medecin De Marseille. Marseille: Impr. D'Achard, 1826; 1:127-31. (with English translation).
- I. Fraser, “An Historical Perspective on Mechanical Aids in Intestinal Anastamosis,” Surg. Gynecol. Obstet. (Oct. 1982), vol. 155, pp. 566-574.
- M.E. Ryan et al., “Endoscopic Intervention for Biliary Leaks After Laparoscopic Cholecystectomy: A Multicenter Review,” Gastrointest. Endosc., vol. 47(3), 1998, pp. 261-266.
- C. Cope, “Creation of Compression Gastroenterostomy by Means of the Oral, Percutaneous, or Surgical Introduction of Magnets: Feasibility Study in Swine,” J. Vasc Interv Radiol, (1995), vol. 6(4), pp. 539-545.
- J.W. Hazey et al., “Natural Orifice Transgastric Endoscopic Peritoneoscopy in Humans: Initial Clinical Trial,” Surg Endosc, (Jan. 2008), vol. 22(1), pp. 16-20.
- N. Chopita et al., “Endoscopic Gastroenteric Anastamosis Using Magnets,” Endoscopy, (2005), vol. 37(4), pp. 313-317.
- C. Cope et al., “Long Term Patency of Experimental Magnetic Compression Gastroenteric Anastomoses Achieved with Covered Stents,” Gastrointest Endosc, (2001), vol. 53, pp. 780-784.
- H. Okajima et al., “Magnet Compression Anastamosis for Bile Duct Stenosis After Duct to Duct Biliary Reconstruction in Living Donor Liver Transplantation,” Liver Transplantation (2005), pp. 473-475.
- A. Fritscher-Ravens et al., “Transluminal Endosurgery: Single Lumen Access Anastamotic Device for Flexible Endoscopy,” Gastrointestinal Endosc, (2003), vol. 58(4), pp. 585-591.
- G.A. Hallenbeck, M.D. et al., “An Instrument for Colorectal Anastomosis Without Sutrues,” Dis Col Rectum, (1963), vol. 5, pp. 98-101.
- T. Hardy, Jr., M.D. et al., “A Biofragmentable Ring for Sutureless Bowel Anastomosis. An Experimental Study,” Dis Col Rectum, (1985), vol. 28, pp. 484-490.
- P. O'Neill, M.D. et al., “Nonsuture Intestinal Anastomosis,” Am J. Surg, (1962), vol. 104, pp. 761-767.
- C.P. Swain, M.D. et al., “Anastomosis at Flexible Endoscopy: An Experimental Study of Compression Button Gastrojejunostomy,” Gastrointest Endosc, (1991), vol. 37, pp. 628-632.
- J.B. Murphy, M.D., “Cholecysto-Intestinal, Gastro-Intestinal, Entero-Intestinal Anastomosis, and Approximation Without Sutures (original research),” Med Rec, (Dec. 10, 1892), vol. 42(24), pp. 665-676.
- USGI® EndoSurgical Operating System—g-Prox® Tissue Grasper/Approximation Device; [online] URL: http://www.usgimedical.com/eos/components-gprox.htm—accessed May 30, 2008 (2 pages).
- Printout of web page—http://www.vacumed.com/zcom/product/Product.do?compid=27&prodid=852, #51XX Low-Cost Permanent Tubes 2MM ID, Smooth Interior Walls, VacuMed, Ventura, California, Accessed Jul. 24, 2007.
- Endoscopic Retrograde Cholangiopancreatogram (ERCP); [online] URL: http://www.webmd.com/digestive-disorders/endoscopic-retrograde-cholangiopancreatogram-ercp.htm; last updated: Apr. 30, 2007; accessed: Feb. 21, 2008 (6 pages).
- ERCP; Jackson Siegelbaum Gastroenterology; [online] URL: http://www.gicare.com/pated/epdgs20.htm; accessed Feb. 21, 2008 (3 pages).
- D.G. Fong et al., “Transcolonic Ventral Wall Hernia Mesh Fixation in a Porcine Model,” Endoscopy 2007; 39: 865-869.
- B. Rubinsky, Ph.D., “Irreversible Electroporation in Medicine,” Technology in Cancer Research and Treatment, vol. 6, No. 4, Aug. 2007, pp. 255-259.
- D.B. Nelson, MD et al., “Endoscopic Hemostatic Devices,” Gastrointestinal Endoscopy, vol. 54, No. 6, 2001, pp. 833-840.
- CRE™ Pulmonary Balloon Dilator; [online] URL: http://www.bostonscientific.com/Device.bsci?page=HCP_Overview&navRe1Id=1000.1003&method=D . . . , accessed Jul. 18, 2008 (4 pages).
- J.D. Paulson, M.D., et al., “Development of Flexible Culdoscopy,” The Journal of the American Association of Gynecologic Laparoscopists, Nov. 1999, vol. 6, No. 4, pp. 487-490.
- H. Seifert, et al., “Retroperitoneal Endoscopic Debridement for Infected Peripancreatic Necrosis,” The Lancet, Research Letters, vol. 356, Aug. 19, 2000, pp. 653-655.
- K.E. Mönkemüller, M.D., et al., “Transmural Drainage of Pancreatic Fluid Collections Without Electrocautery Using the Seldinger Technique,” Gastrointestinal Endoscopy, vol. 48, No. 2, 1998, pp. 195-200, (Received Oct. 3, 1997; Accepted Mar. 31, 1998).
- D. Wilhelm et al., “An Innovative, Safe and Sterile Sigmoid Access (ISSA) for NOTES,” Endoscopy 2007, vol. 39, pp. 401-406.
- Nakazawa et al., “Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin,” AJR, 188, pp. 480-488 (Feb. 2007).
- Miklav{hacek over (c)}i{hacek over (c)} et al., “A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy,” Biochimica et Biophysica Acta, 1523, pp. 73-83 (2000).
- Evans, “Ablative and cathether-delivered therapies for colorectal liver metastases (CRLM),” EJSO, 33, pp. S64-S75 (2007).
- Wong et al., “Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations,” AJR, 190, pp. W187-W195 (2008).
- Heller et al., “Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo,” Gene Therapy, 7, pp. 826-829 (2000).
- Widera et al., “Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo,” The Journal of Immunology, 164, pp. 4635-4640 (2000).
- Weaver et al., “Theory of electroporation: A review,” Bioelectrochemistry and Bioenergetics, 41, pp. 135-160 (1996).
- Mulier et al., “Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?” Annals of Surgical Oncology, 15(1), pp. 144-157 (2008).
- Link et al., “Regional Chemotherapy of Nonresectable Colorectal Liver Metastases with Mitoxanthrone, 5-Fluorouracil, Folinic Acid, and Mitomycin C May Prolong Survival,” Cancer, 92, pp. 2746-2753 (2001).
- Guyton et al., “Membrane Potentials and Action Potentials,” W.B. Sanders, ed. Textbook of Medical Physiology, p. 56 (2000).
- Guyton et al., “Contraction of Skeletal Muscle,” Textbook of Medical Physiology, pp. 82-84 (2000).
- “Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages,” Apr. 22, 2009 Press Release; URL http://www.jnj.com/connect/news/all/20090422_152000; accessed Aug. 28, 2009 (3 pages).
- “Ethicon Endo-Surgery Studies Presented At DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox,” Jun. 3, 2009 Press Release; URL http://www.jnj.com/connect/news/product/20090603_120000; accessed Aug. 28, 2009 (3 pages).
- Castellvi et al., “Hybrid Transvaginal NOTES Sleeve Gastrectomy in a Porcine Model Using a Magnetically Anchored Camera and Novel Instrumentation,” Abstract submitted along with Poster at SAGES Annual Meeting in Phoenix, AZ, Apr. 22, 2009 (1 page).
- Castellvi et al., “Hybrid Transvaginal NOTES Sleeve Gastrectomy in a Porcine Model Using a Magnetically Anchored Camera and Novel Instrumentation,” Poster submitted along with Abstract at SAGES Annual Meeting in Phoenix, AZ, Apr. 22, 2009 (1 page).
- OCTO Port Modular Laparoscopy System for Single Incision Access, Jan. 4, 2010; URL http://www.medgadget.com/archives/2010/01/octo_port_modular_laparo . . . ; accessed Jan. 5, 2010 (4 pages).
- Hakko Retractors, obtained Aug. 25, 2009 (5 pages).
- Zadno et al., “Linear Superelasticity in Cold-Worked Ni—Ti,” Engineering Aspects of Shape Memory Alloys, pp. 414-419 (1990).
- How Stuff Works “How Smart Structures Will Work,” http://science.howstuffworks.com/engineering/structural/smart-structure1.htm; accessed online Nov. 1, 2011 (3 pages).
- Instant Armor: Science Videos—Science News—ScienCentral; http://www.sciencentral.com/articles./view.php3?article_id=218392121; accessed online Nov. 1, 2011 (2 pages).
- Stanway, Smart Fluids: Current and Future Developments. Material Science and Technology, 20, pp. 931-939, 2004; accessed online Nov. 1, 2011 at http://www.dynamics.group.shef.ac.uk/smart/smart.htm (7 pages).
- Jolly et al., Properties and Applications of Commercial Magnetorheological Fluids. SPIE 5th Annual Int. Symposium on Smart Structures and Materials, 1998 (18 pages).
- Rutala et al. “Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008” (available at http://www.cdc.gov/hicpac/Disinfection_Sterilization/13_11sterilizingPractices.html).
- Bewley et al., “Spinning” in ASM Handbook, vol. 14B, Metalworking: Sheet Forming (2006).
- Schoenbach et al. “Bacterial Decontamination of Liquids with Pulsed Electric Fields” IEEE Transactions on Dielectrics and Electrical Insulation. vol. 7 No. 5. Oct. 2000, pp. 637-645.
- Davalos, et al., “Tissue Ablation with Irreversible Electroporation,” Annals of Biomedical Engineering, 33.2 (2005): 223-231.
- International Preliminary Report on Patentability for PCT/US2013/052250, dated Feb. 3, 2015 (10 pages).
- Written Opinion for PCT/US2013/052250, dated Oct. 29, 2013 (9 pages).
- European Examination Report for 13750419.7, dated Nov. 8, 2016 (7 pages).
- Maxim Integrated Application Note 3977: Class D Amplifiers: Fundamentals of Operation and Recent Developments, Jan. 31, 2007.
Type: Grant
Filed: Aug 2, 2012
Date of Patent: Jun 11, 2019
Patent Publication Number: 20140039491
Assignee: Ethicon Endo-Surgery, Inc. (Cincinnati, OH)
Inventors: Gregory J. Bakos (Mason, OH), David N. Plescia (Mentor, OH), Gary L. Long (Cincinnati, OH), Peter K. Shires (Hamilton, OH)
Primary Examiner: Christopher Koharski
Assistant Examiner: Elizabeth K So
Application Number: 13/565,307
International Classification: A61B 18/18 (20060101); A61B 18/14 (20060101); A61B 17/00 (20060101); A61B 18/00 (20060101);